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Abstract 
 
Muscle weakness, as measured by hand grip strength, has been shown to be an important 
indicator of future disability, chronic disease status and early mortality. While muscle weakness 
is considered an important prognostic indicator, how best to measure weakness, the long term 
health outcomes associated with muscle weakness across different sub-populations and the life 
course determinants remain poorly understood. Indeed, there is little agreement on how best to 
measure muscle weakness across different groups and how to screen for muscle weakness in 
order to prevent disability and premature mortality.  
We begin by first deriving cutpoints for muscle weakness in a nationally representative 
sample of older adults from the Health and Retirement Study. After using Classification and 
Regression Tree (CART) models to identify cutpoints, we found that fifty-five percent of men 
(max grip strength <39kg) and 47% of women (<22kg) were classified as weak. Higher cutpoints 
were identified for Black males (<40kg) and females (<31kg), and the prevalence of weakness 
(57% and 88%, respectively), was higher compared to Whites. 
As an extension to these results, we examine the validity of these cutpoints in a 
longitudinal setting to determine whether muscle weakness is associated with disability 
dynamics and premature mortality. We found that clinical muscle weakness, as identified by 
sex/race specific population-derived cutpoints from Aim 1, is strongly associated with the onset, 
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progression and persistence of physical disability status. The odds of experiencing an onset of 
ADL disability were 54% higher among weak individuals compared those who were not weak at 
baseline. We also found that weak individuals had a steeper decline in their survival trajectory, 
compared to non-weak individuals. Specifically, weak individuals were over 50% more likely to 
die earlier than non-weak individuals. 
Lastly, the third aim of this dissertation seeks to quantify and understand whether 
experiencing stressful and traumatic events across the life course influences trajectories of grip 
strength in later life. We found that life course trauma and stress experienced during 
emerging/early adulthood was associated with both mean grip strength at age 50 and trajectories 
of grip strength over time. Among Black men, stress and trauma experienced during 
emerging/early adulthood was not only related to higher mean grip strength at age 50, but also 
associated with steeper declines as individuals aged over time compare to White men. Among 
Black women, traumatic events during emerging/early adulthood were associated with lower 
mean grip strength at age 50.  
Taken together, the results of this dissertation chart new territory in its overall goal to 
improve the measurement of muscle health across the diverse, older adult population and in 
identifying those most at risk for future disability and premature mortality. This dissertation also 
demonstrates the importance of investigating how life course social exposures drive differential 
vulnerability to muscle weakness among older adults. The results of this dissertation can be used 
to inform clinical practice in screening adults for muscle weakness while also seeking to shift the 
distribution of muscle weakness at the population level in order to intervene among those who 
are most vulnerable. 
 
 
 1 
CHAPTER 1.  Background 
1.1 National Trends in Aging 
The growth of the population of those aged 65 years and older is unprecedented and 
represents one of the most significant demographic shifts of recent time. Today, it is estimated 
that 46 million Americans are 65 years and older and this number is expected to more than 
double to 98 million by 2060.1 Additionally, the number of individuals aged 85 years and older is 
estimated to triple from 6 million to nearly 20 million by 2060.1 There has also been a rapid rise 
in the number of centenarians, or those aged 100 years and older. In 2010, roughly 53,000 
individuals were 100 years or older and this number is expected to rise to 600,000 by 2060.2   
In addition to the rapid growth of Americans aged 65 years and older, the U.S. population 
is also becoming more racially and ethnically diverse. Today, while 75 percent of those aged 65 
years and older are predominately non-Hispanic White, current trends indicate that between 2030 
and 2060, the number of non-Hispanic White individuals will drop by 17 percentage points. It is 
estimated that that the number of Hispanics aged 65 years and older will almost double from 11 
to 22 percent by 2060.1 During this same time period, Black population is also expected to 
increase from 41.2 to 61.8 million.1 The aggregate minority population in the United States today 
is projected to become the majority by 2043.3
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At the same time, life expectancy in the U.S. has increased. As of 2013, the average life 
expectancy was 79 years, compared to 68 years in 1950. This is largely attributed to reductions 
in mortality in older age.3 Healthy life expectancy, defined as the number of disability-free years 
a person is expected to live, has also been increasing. Indeed, recent research indicates that 
between 1992 and 2008, overall healthy life expectancy among those aged 70 years and older 
increased by 1.8 years.4 However, despite these gains, the current health status of Baby Boomers, 
those born between 1946 and 1964, indicate they are not fairing nearly as well. While Baby 
Boomers are less likely to smoke, have heart attacks or be diagnosed with emphysema, they are 
more likely to be obese or overweight, have higher rates of diabetes and high blood pressure, and 
be less active compared to previous birth cohorts at the same ages.5 Thus, as Baby Boomers 
move into the ranks of the older adult population by 2030, it is possible that recent gains made in 
healthy life expectancy may soon be eroded.  
1.2 Living Longer, Aging Well? The Importance of Studying Muscle Strength 
The increase in life expectancy coupled with rising obesity rates have given rise to major 
concerns regarding the forecasted prevalence of disability in later life. Indeed, despite previous 
trends documenting a decrease in the overall rate of disability among older persons, recent 
research indicates that obese individuals are more likely to be disabled compared to obese 
individuals over a decade ago.6 This has important implications since there is growing evidence 
that the excess risk of disability exceed obesity’s excess risk of mortality.7 Recent data from the 
National Health and Nutrition Examination Survey (NHANES) revealed a significant increase in 
obesity among the “young old”, those aged 65 to 74.8 Similarly, the number of people aging with 
chronic disease has also increased. Today, older adults are more likely to age with cardiovascular 
disease, cancer, diabetes mellitus, and dementia, all of which have been shown to be related to 
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physical functioning, disability and premature mortality.9,10 These data are worrisome because 
they indicate that, while individuals may be living longer, it does not necessarily mean they are 
living well. Given recent demographic trends forecasting major increases in the prevalence of 
disability among older adults, understanding the key indicators that reduce disability while 
maximizing independence in older age is of critical public health importance.11,12 
Advanced age is accompanied by a host of physiologic changes and an increase in co-
morbidities that have been directly linked to health status and quality of life.11 Chief among these 
changes is a decline in muscle mass and strength, also known as “sarcopenia”. While age-related 
losses in muscle strength and mass are part of the normative aging process, individuals who 
undergo steeper declines in muscle strength may be more vulnerable to adverse outcomes in later 
life 13,14. Indeed, sarcopenia has been linked to increased risk of physical disability, mobility 
limitations and premature mortality.15–17 Annual direct costs attributable to compromised muscle 
functioning are estimated at around $20 billion in the United States.18 Therefore, understanding 
how to measure, define and prevent muscle weakness in later age is a major public health 
concern. 
1.3 Epidemiology of Muscle Weakness 
It is estimated that skeletal muscle mass decreases by 50% on average between 20 and 90 
years of age 19. Similarly, muscle strength declines about 15% every decade beginning at age 50 
and accelerates at age 70 with about 30% of strength being lost per decade thereafter 20. Muscle 
weakness, also known as “dynapenia”, was first described as an “age-related loss in strength that 
is not cause by neurologic or muscular diseases” 21 and has been found to be a primary 
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determinant of age-related loss of function, 22,23  mobility disability, 14,24,25 cardiovascular 
disease26  and mortality 26,27.   
Using the most recent criteria for muscle weakness from the Foundation for the National 
Institutes of Health (FNIH), the CDC recently estimated that among those 60 years and older, 
5% are considered weak while 19% of individuals aged 80 years and older are considered weak 
28. While the consequences of muscle weakness for both men and women between the ages of 
60-79 years are comparable (2% prevalence), sex disparities in muscle weakness have been 
observed in those aged 80 years and older: 15% of men and 22% of women are estimated to be 
weak28.  Differences in muscle strength have also been reported by race/ethnicity: 5% of Non-
Hispanic Whites, 6% of Non-Hispanic Blacks, 15% of Non-Hispanic Asians and 9% of 
Hispanics are estimated to have muscle weakness. However, it’s worth nothing that this FNIH 
definition has yet to be fully accepted by some members of the scientific community and to date, 
no clear consensus exists regarding how best to measure muscle weakness at the population 
level. 
Historically, muscle mass has been treated as the most important marker of overall muscle 
health. When the term “sarcopenia”, formally defined as an age-related loss in muscle mass, was 
first coined in 1989, muscle strength was not acknowledged as an independent indicator of 
muscle health. However, beginning in the early 2000s, the muscle health literature began 
focusing on muscle strength as a separate risk factor that warranted individual examination. 
Despite recent efforts to delve deeper into the study of muscle weakness, a substantial body of 
research has exclusively focused only on the declines in muscle mass without considering the 
role of muscle strength29. 
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The difficulty in studying muscle health has largely centered around what aspect of 
muscle health is most clinically relevant and how best to measure those components—should we 
focus on muscle mass? Strength? Quality? Since the 1980s, this debate has actively played out in 
the literature and continues to do so today. As evidenced by the most recent literature in this 
area, there is no single standardized, agreed upon definition as to how best to measure muscle 
health with respect to both strength and mass in older populations.  
The examination of muscle weakness as an important contributing factor to aging related 
morbidity and mortality has not been linear.  In 1988, a conference convened in Albuquerque, 
New Mexico focused on measurement issues in the field of health and nutrition among elderly 
adults. It was as this meeting that Irwin Rosenberg first coined the term “sarcopenia” and 
declared it to be a serious public health condition30. In a commentary by Rosenberg, he reflected:  
“I noted then that no decline with age is as dramatic as or potentially more significant 
than the decline in lean body mass. In fact, there may be no single feature of age-related 
decline more striking than the decline in lean body mass in affecting ambulation, 
mobility, energy intake, overall nutrient intake and status, independence and breathing. I 
speculated as to why we had not given this more attention a suggested that if this 
phenomenon were to be taken seriously, we had to give a name. This would provide 
recognition by the scientific community by the NIH. I proposed that the name for this 
phenomenon be derived from the Greek. I remind you that ‘sarx’ in Greek is flesh and 
‘penia’ is loss.” (pg. 990S) 30.   
As demonstrated in the above quote, Rosenberg’s definition of sarcopenia solely focused on 
muscle mass without any mention of the role muscle strength may play. Shortly after, the first 
epidemiological studies examining sarcopenia measured muscle mass using body impedance 
analysis (BIA) or dual-energy X-ray absorptiometry (DXA) to assess sarcopenia in aging 
individuals.  In one of first pioneering studies in this area, Baumgartner et al. were the first to use 
DXA, corrected for height, to formally define sarcopenia as two standard deviations below sex 
specific means of healthy young persons (18-40 years) of a reference population 31. Based on this 
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definition, the prevalence of sarcopenia was estimated to be 50% in adults aged 80 years and 
older and that sarcopenia was also found to be associated with higher rates of self-reported 
disability 31. This was the first study to demonstrate that muscle health had important 
implications for the field of public health and aging.  
Since this seminal study, over one-thousand publications have used this definition19.  
Nonetheless, as the field continued to evolve, this original definition received major criticism on 
account of two methodological concerns. First, while DXA scans are considered the gold 
standard in measuring body composition, the results are highly dependent on water accumulation 
within the muscles, which can lead to an overestimate in one’s lean muscle mass. Second, this 
definition assumed that as muscle mass decreased, there is a concomitant decline in muscle 
strength, 29 which had not been proven. On the contrary, as the research on muscle strength 
began to accumulate, several studies showed that declines in muscle strength outpaced that of 
muscle mass 12,32–34, implying that muscle strength may not only be an important predictor of 
muscle health but a better measurement with respect to clinical intervention compared to muscle 
mass.  
1.4 Limitations of Only Relying on Muscle Mass 
 In an effort to highlight the differences in the operational definitions of sarcopenia 
influence the prevalence estimates of the condition, Batsis et al. quantified the prevalence of 
sarcopenia using NHANES data based on 8 different study definitions of sarcopenia 35. Seven of 
the studies used DXA scans while 1 used BIA to formally assess body composition. Three 
studies diagnosed sarcopenia at 2 standard deviations below the mean appendicular skeletal 
muscle mass of the subject-specific cohort or a healthy reference population. Three studies 
diagnosed sarcopenia at the lowest two quintiles for relative muscle mass within the study 
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sample. In the other two studies, individuals who fell 2 standard deviations below the sex-
specific normal means for a young reference population were considered sarcopenic.  
Based on these definitions, across all eight studies, in men, the prevalence of sarcopenia 
ranged from 10 to 80% in 60-69 year olds, 20 to 82% in 70-79 year olds and 20 to 93% in those 
aged 80+ years 35.  Similarly, in women, the prevalence of sarcopenia among those aged 60-69 
years ranged from 10 to 96%, 9 to 96% for those 70-79 years of age and 8 to 97% in those aged 
80+ years 35. This study was the first to highlight how the range in sarcopenia definitions, which 
only accounted for muscle mass, contributed to major heterogeneity in the prevalence estimates 
of sarcopenia using nationally representative data. 
As a result, Clark and Manini called on the research community to reconsider the 
definition of sarcopenia as a term that applies only to declines in muscle mass. In their 
groundbreaking article entitled “Sarcopenia ≠ Dynapenia”, the authors noted that applying the 
term sarcopenia to the study of muscle strength implied a causal relationship between muscle 
mass and muscle strength, which was incorrect and resulted in a literature that overemphasized 
the role of muscle mass. Thus, the authors proposed a new operational term, known as 
“dynapenia”, be used in the study of muscle strength:  
“It is imperative that a greater understanding of the mechanisms of age-associated losses 
in strength be developed. Therefore, to encourage research endeavors focusing on 
understanding the mechanisms of strength, we propose changes in the nomenclature that 
distinctly separates the age-associated changes in muscle mass and strength. We suggest 
that sarcopenia be limited to its original definition of an age-related loss in skeletal 
muscle mass, and that the term “dynapenia” be applied to describe the age-related loss of 
strength.” (pg. 829)29. 
As a result of this distinction, several expert groups such as the International Working Group on 
Sarcopenia, The European Working Group on Sarcopenia in Older People, and other researchers, 
sought to incorporate strength based measures into their definition of sarcopenia 22,23. While this 
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represented an important step forward, these definitions were also criticized since they did not 
rely on evidenced-based research and suffered similar methodological flaws to that of the 
original Baumgartner definition36. These methodological shortcomings included: relying on 
standard referent populations 22,23, using non-representative data24,  and a lack of uniform body 
composition measurement techniques to assess muscle mass (i.e., DXA, BIA, etc.) or strength 
(i.e., grip strength, leg extensor strength)22–24,37, which ultimately translated into vast differences 
in how both sarcopenia and dynapenia were defined and quantified. These definitions were also 
derived in cross-sectional study samples where the long-term health outcomes had not been 
evaluated 22,23.  Additionally, when the muscle mass and strength based definitions were first 
applied within longitudinal settings to examine long-term outcomes, the preponderance of 
evidence was mixed 12,32,38 and pointed to the fact that muscle mass may be a poor predictor of 
health and functioning while muscle strength as a single indicator may be more important to 
examine and intervene upon over time.  
1.5 Measuring Muscle Weakness: Making the Case for Hand Grip Strength 
The case for examining muscle strength in older populations extends beyond recent studies 
showing muscle weakness is a better indicator than muscle mass. Indeed, there are several 
important methodological advantages to measuring total body muscle weakness instead of 
muscle mass. First, previous research has demonstrated that handgrip strength, an easily 
obtainable indicator, is highly correlated with other reliable and valid measurements of total 
body muscle strength, including elbow flexion strength (r=. 67), knee extension strength (r=. 51) 
and trunk extension strength (r=. 54) 39. Second, grip strength has been found to be 
independently associated with functional limitations 14,24,40 , disability 14,41, incident CVD26,  
diabetes42 and mortality26,39.  Mid-life grip strength has even been found to be associated with 
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incident negative health outcomes 25 years later 14. Third, grip strength measurements can easily 
be measured by a dynamometer, a small, simple and inexpensive device that an individual 
squeezes to obtain an overall value of strength (usually in kilograms) that is both easy to 
administer and non-invasive 43.  Based on these findings, hand grip strength is now accepted as a 
strong, robust proxy for total body muscle strength14,40,44. Given the strong association between 
grip strength and several important negative health outcomes combined with its ease in 
administration, it has been suggested that grip strength measurements be incorporated into 
clinical examinations in order to identify individuals who may be most at risk to adverse health 
events 39,40,42,44. Yet, despite the clear advantages of this approach and acceptance of grip 
strength as a reliable proxy of total body muscle strength, there is still no consensus as to what is 
considered low muscle strength or “true weakness” across different populations. 
In 2012, the Foundation for the National Institutes of Health became the latest group of 
experts to weigh in on how best to measure both low muscle strength and mass. The FNIH 
“Sarcopenia Project” was founded as a private-public partnership that included representatives 
from government, academia, and the pharmaceutical industry and was created amidst growing 
frustrations by the lack of consensus on how best to define low muscle mass and weakness. The 
primary goal of the project was to “gather together previously collected data from multiple, 
diverse cohorts of older adults, including both observation studies and randomized trials, with 
longitudinal measures of muscle mass and function, to conduct analyses to develop definitions of 
muscle weakness and low lean mass that were clinically oriented, evidence-based and 
empirically derived” (pg. 589)45.  Based on this approach, the FNIH pooled together eight 
observational cohort studies and six clinical trials, which included 26,000 men and women aged 
65 years and older36.  
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 In a series of 5 papers 36,37,46–48, the FNIH proposed diagnostic cutpoints for both low 
muscle appendicular muscle mass and muscle strength for both men and women based on having  
mobility impairment, which they defined as having a slow walking speed of less than 0.8 meters 
per second 36. They also longitudinally examined the association between these cutpoints and 
mobility impairment and mortality across a 3-year period 47. They stated that these proposed 
cutpoints should be used in the clinical setting to identify individuals who may have “low muscle 
lean muscle mass or weakness” (pg. 549) 36. As such, the FNIH refrained from using the term 
“sarcopenia” or “dynapenia” due to “prior confusion” 36 around the many previous definitions 
that had been proposed. Nonetheless, the FNIH cutpoints for lean mass and muscle weakness 
have become the clinical gold standard and are already being used in clinical practice 49–51. 
 The FNIH proposed guidelines to classify older adults as clinically weak based on having 
a low grip strength cutpoints (25.99 kg for men and 15.92 kg for women)36,37. However, these 
cutpoints were derived from non-nationally representative, pooled data across 8 observational 
and 6 clinical trial studies that do not reflect the growing racial and ethnic diversity in the U.S. 
population37.  Therefore, part of this dissertation will examine sex and race/ethnic specific 
cutpoints for clinical weakness in a nationally representative sample of Black and White older 
adults. 
1.6 Hand Grip Strength: A Biomarker of Healthy Aging 
The perception of grip strength as a “biomarker of aging” may be apropos because it of 
its strong predictive relationship with a wide range of negative health outcomes. 17 Grip strength 
has been shown to be useful in identifying those who may be at greatest risk for adverse 
events14,26,41–43. While the mechanisms underlying the strength-health pathway are poorly 
understood, there are likely several potential mechanisms at play. First, the strength-health 
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association may be fully or partially mediated through physical activity. 39 That is, once an 
individual becomes weak they may be less likely to maintain physical activity, leading to a 
greater risk of disability, chronic disease risk and early mortality. However, it is also well 
established that individuals with low levels of physical activity are more likely to become weak 
due to an increase in muscle atrophy over time, and as a result, more vulnerable to the 
consequences of disability and at greater fall risk. 52 Second, repeated exposure to stressful life 
events and social adversity might also influence muscle strength over time. While the mechanism 
by which social stress and trauma could affect muscle strength is not well studied, the distinct 
physiologic cascade the takes place following exposure to stressful events is well documented.53 
Furthermore, exposure to chronic stress, such as those negative events that persist over time (i.e., 
taking care of a sick family member) or experiencing an acute, traumatic event (i.e., being the 
victim of a crime) are believed to be the most potent forms of stress.54  
When a stress response is activated, cortisol is released by the hypothalamic-pituitary-
adrenocortical (HPA) axis. While the initial release of cortisol and other hormones is viewed as 
adaptive by slowly digestion and breaking down metabolic compounds in order to quickly 
produce energy, cortisol remains elevated the longest amount of time in the body.54 This has 
been replicated over decades of research demonstrating that repeated activation of the HPA 
pathway is harmful to health. The proposed mechanism, increased inflammation, has grave 
implications for multiple bodily systems, including, but not limited to, the skeletal muscle 
system.53,54 Indeed, higher levels of interleukin-6 (IL-6), interleukin-1 receptor (IL-1R) and 
tumor necrosis (TNF) and C-reactive protein (CRP), all primary markers of an elevated 
inflammatory state, have been found to be associated with reduced muscle strength.55,56  
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Lastly, another potential pathway that could mediate the strength-health association is 
through nutritional intake. Studies have shown that older adults with comprised nutritional status 
may be at greater risk for becoming weak. Specifically, individuals with low levels of vitamin 
E,57 carotenoids, 58 and selenium 59 have been found to have lower muscle strength, however the 
mechanisms underlying this relationship are not fully understood. Indeed, teasing apart the 
muscle-health relationship is difficult to establish due to problems of reverse causality and the 
need to further elucidate the underlying, complex physiologic mechanisms. 
1.7 Muscle Weakness and Frailty 
In the last 20 years, growing interest into the study of muscle weakness and physical 
frailty has led to the development of two parallel literatures. In general, sarcopenia and muscle 
weakness has largely been examined within the basic science research realm while the study of 
frailty has occurred in the applied, clinical setting.60 While sarcopenia is typified by losses in 
muscle mass and strength, frailty is a clinical syndrome that is characterized by multi-system 
impairments “associated with increased vulnerability to stressors” that results in an increased risk 
to negative health outcomes.61 
The complex interplay between muscle weakness and frailty has been noted extensively 
in the literature.62–65 One primary example of this is the widely used Fried Frailty Index (FFI), 
which includes muscle weakness as a primary indicator of frailty in addition to unintentional 
weight loss, poor endurance and energy, low physical activity and slow walking speed.63 In order 
for an individual to meet criteria for the weakness indicator, they have must fall below stratified 
sex and BMI cutpoints. For example, a man who has a BMI of 27 would be considered weak if 
he had a grip strength measurement of ≤30 kg and a woman who has a BMI ≤23 would be 
considered weak if she had grip strength ≤17 kg.63  
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1.8 Muscle Weakness and Physical Disability 
Previous studies have found a strong association between muscle weakness and functional 
limitations 14,24,40 and disability. 14,41 One possible explanation for this is that individuals with 
higher levels of muscles strength are believed to have a built-in “reserve” that protects them from 
future disability compared to those who are weaker. Thats is, having adequate muscle strength is 
needed in order to perform basic activities of daily living.  
There is a well-established body of work demonstrating that muscle weakness is 
consequential in maintaining physical functioning in later life. For example, Rantanen et al. 
found that individuals in the lowest tertile of grip strength were at greater odds of experiencing 
difficulty when doing heavy household work, walking a ½ mile, walking up 10 stairs, lifting 
4.5kg, dressing, bathing, toileting and eating 25 years later compared to those in the middle and 
highest grip strength tertiles, even after adjusting for other chronic conditions, age, education, 
height, physical activity, and smoking status. 14 In a 3-year longitudinal study by Onder et al., 
higher handgrip strength was found to be protective against incident ADL disability.66 Giampaoli 
et al. found that after adjusting for age, the incidence of disability in older men, defined by 
difficulty with any ADL or IADL, increased with decreasing muscle strength from 26% in the 
highest quartile to 48% in the lowest quartile of hand grip strength across the 4-year period.67  
Using data from the Health and Retirement Study, Germain et al. found that tertile-
specific low muscle strength was associated with higher odds of physical and functional 
outcomes, although those analyses were cross-sectional.68 Additionally, a 4-year longitudinal 
study found that higher handgrip strength was associated with a reduced risk in the development 
of new functional difficulties.69 Taken together, these results, along with other studies, 12,40,41,47 
imply that a minimum level of muscle strength is needed to do everyday tasks as one ages and 
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that those who are at weak may be more vulnerable to the consequences of disability in later age 
70.  
1.9 Muscle Weakness and Premature Mortality 
Muscle strength has also been found to be highly predictive of early mortality. Indeed, 
there a growing body of research has documented that muscle weakness, as measured by hand 
grip strength, is associated with mortality.12,13,17,26,71–73 Several epidemiological studies have 
found grip strength to be inversely related to all-cause and cause-specific mortality in mid-life74–
77, older12,17,47,78 and the oldest old79 populations, although in a few studies, this relationship held 
for men but not women.17,71 In a meta-analysis by Cooper et al. comprised of 14 studies and 
close to 54,000 participants, those in the lowest quartile of grip strength measurement were 67% 
more likely to die earlier compared to those in the highest quartile, even after adjusting for sex, 
body mass and age.27  In the PURE study among nearly 140,000 adults 35-70 years of age with 4 
years of follow-up, Leong and colleagues demonstrated that poor grip strength was the strongest 
predictor of early cardiovascular and all-cause mortality, even compared to other traditional 
clinical indicators such as systolic blood pressure.26 Thus, muscle strength remains an important 
and robust predictor of mortality risk as individuals’ age over time. 
While the mechanisms underlying the muscle weakness-mortality association have not 
been fully elucidated, several studies have shown muscle weakness to be associated with higher 
fasting insulin levels80 and a precursor to insulin resistance.81 Muscle weakness has also been 
found to be independently associated with an increased odds of experiencing diabetes42,82 and 
metabolic syndrome in adults. 83 Maintaining muscle strength may play a critical role in 
preventing metabolic and cardiovascular disease risk with aging, and thus protecting against 
premature mortality. 
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Weak individuals are also more likely to report greater difficulty in completing basic self-
care activities 13,14 and experience greater odds of disability onset, progression and persistence 
over time.15 Therefore, the association between muscle weakness and mortality may be mediated 
by changes in physical functioning. Individuals with low levels of physical activity are more 
likely to experience declines in muscle strength, thereby entering a negative feedback loop where 
weak individuals are unable to participate in physical activity and are more vulnerable to 
declines in their physical health status, leading to subsequent declines and risk for early 
mortality.  Taken together, handgrip strength may function as a “a crude but effective will to live 
meter”84 even if the underlying mechanisms of the strength-mortality association may not be 
fully understood.85  
1.10 Life Course and Social Determinants of Muscle Weakness 
Life course epidemiology has been used to elucidate how seemingly unrelated physical 
and social exposures experienced during gestation, childhood, adolescence, young adulthood and 
middle age drive disease outcomes in later life.86 Life course epidemiology’s theoretical 
underpinnings are driven by a developmental perspective in which distinct time periods are 
marked by specific life events and transitions where certain stressors/protective factors may be 
more or less likely to occur.86,87 For example, childhood is often defined by gains in education 
while adolescence is an important window of development when young people begin to assert 
their independence, make life style choices and establishes health behaviors that will often 
persist into adulthood.88 The emerging/early period of adulthood is best characterized by the 
establishment of one’s career, marriage, parenthood and asset acquisition that has a lasting 
effects on health and SES in later life.89–91 Lastly, the midlife period (mid 40s to early 60s) is 
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often typified by gains (or losses) in health status as a result of early health behaviors and 
exposures.  
Two conceptual models within life course theory have been proposed to understand how 
antecedent events drive health outcomes in older age: the critical period and the accumulation of 
risk models.86 The critical period model suggests that a specific life stage in which an individual 
experiences adverse exposures may have crucial consequences on their health in later life. This 
conceptual model is largely rooted in the fetal origins hypothesis, which linked poor maternal 
nutrition in utero to increased risk of coronary heart disease and diabetes in later life.92 One well 
documented example is literature showing that childhood SES is directly associated with 
cardiovascular disease,93 stroke,94,95 physical functioning96,97 and lower levels of grip strength98 
in older adults. Similarly, experiencing physical, sexual and emotional abuse during childhood is 
associated with increased risk of adverse physical and mental health outcomes in later life. 99,100  
The accumulation of risk model posits that negative exposures gradually accumulate 
across the life course, ultimately influencing health status in later life.101 This model has been 
used to explain why socioeconomic differentials in health exist across a wide range of diseases.86 
For example, early childhood conditions may set individuals on risk trajectories of cumulative 
advantage/disadvantage with those from lower SES backgrounds experiencing a faster decline in 
health compared to those from higher SES backgrounds, ultimately leading to widening health 
disparities in later life.102,103 The accumulation of risk model has been applied to examine 
physical health outcomes. For example, physical inactivity, smoking, heavy drinking, social 
isolation, fair/poor perceived health and prevalence of chronic symptoms and conditions across a 
30-year period of emerging and midlife adulthood was associated with increased risk of frailty in 
a community dwelling sample of older adults.104  
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There is also growing interest in the role early and midlife factors play in the preservation 
of muscle strength in later life. However, the majority of research has almost exclusively focused 
on anthropometric indicators showing higher birth weight to be associated with greater muscle 
strength adulthood.105 In the Hertfordshire Ageing Study, lower birth weight and weight at year 
one was significantly associated with lower grip strength 60-70 years later. This relationship, 
while somewhat attenuated, remained significant after adjusting for body size, indicating that 
one’s early environment may be of critical underlying importance.106 Pre-pubertal growth has 
also been found to be associated with midlife grip strength.107 
More recently, several studies have demonstrated that socioeconomic conditions 
experienced across the life course may also be linked to muscle health in later life. A recent 
systematic review found modest, positive associations between childhood SES and later life grip 
strength, even after adjusting for adult SES and current body size.97 Wealth in later life was 
found to be inversely associated with grip strength in a sample of older Europeans, while 
education, income and occupation were not, suggesting that earnings accrued across the life 
course may be important in maintaining grip strength in later life.108 Results from a British birth 
cohort study indicated that higher levels of material deprivation (i.e., not having a car, not 
owning one’s home) were inversely related to grip strength in later life.98 Low income and low 
education were found to be significantly associated with decreased grip strength among an 
elderly sample of Korean men.109 More recently, childhood misfortune was found to be related to 
lower handgrip strength in men, but not in women. 110   
A substantial body of literature has demonstrated that one’s social context is 
consequential for health. Previous studies have found social and economic hardships   
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experienced both in childhood111 and throughout the life course are associated with mental and 
physical health outcomes in later life.112,113 There is evidence to suggest that exposure to stress 
and trauma throughout one’s life may be linked to poorer health outcomes in later life. Indeed, 
social stress has been found to be associated with mental health status and depression among 
older adults.114,115 Traumatic events have been shown to have a strong relationship on both 
immediate and long-term health outcomes. Trauma in particular may be especially consequential 
for health. Pearlin (2005) noted that trauma may be the most potent forms of stressors, 
characterized by their “magnitude of their onerousness…and by their sudden and violent 
character” (pg. 210) that have negative consequences for health in later life.116 Despite the 
known links between stress and trauma with later life physical health, no studies have directly 
examined whether stress and trauma experienced throughout the life course is associated with 
muscle health in later life.  
1.11 Emerging Racial/Ethnic Disparities in Muscle Weakness 
Racial/ethnic disparities in health are pervasive and persistent in the United States.117 Non-
Hispanic Blacks are have a higher prevalence of several chronic conditions, 118 live more years 
with chronic health problems119 and have higher rates of disability120,121 compared to Non-
Hispanic Whites. Similarly, among sub-groups of Hispanics, Hispanics have been found to have 
higher rates of chronic disease and have worse functional health.122,123 However, mortality rates, 
particularly among Mexican Americans, appear to be comparable and in some cases exceed all-
cause mortality for Non-Hispanic Whites.124 Racial/ethnic disparities in physical functioning, 
mobility and disability are also well documented.119,121,125,126 
In seeking to understand why these disparities persist, many studies have examined 
socioeconomic status (SES) as a key explanatory contributor. Indeed, several studies have shown 
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that after accounting for SES, disparities in functional health between Blacks and Whites become 
partially attenuated, and in some cases, disappear121,127. However, the evidence regarding the 
association between SES and functional health remains equivocal. Other studies investigating 
this relationship have found that even after accounting for SES differences, disparities in 
disability and physical functioning persist, 128 suggesting that other explanatory factors may be at 
play. 
While little research exists examining the relationship between race/ethnicity and muscle 
weakness specifically, several studies have demonstrated that disparities in physical health 
outcomes persist across racial/ethnic groups. Blacks have been shown to have higher rates of 
disability and physical functioning impairments compared to Whites. 120,121,129 Haas et al. found 
that US-born Blacks and Hispanics had slower gait speeds. US-born Blacks had worse lung 
function and US-born Hispanics had worse grip strength compared to US-born Whites. 
Moreover, even after adjusting for childhood and adult health and SES, US-born Blacks had 
worse health across all physical performance measures compared to Whites. 130  Seeman et al. 
found that Blacks had lower scores on a physical performance index, which included grip 
strength, compared to Whites and were more likely to show steeper declines over time. 131  Using 
data from the Hispanic EPESE study, Snih et al. found that hand grip was found to be an 
independent predictor of disability status among an older cohort of Mexican Americans 41. 
Although Hispanics, specifically Mexican Americans, have mortality rates comparable to that of 
Whites, they are more likely to live more disabled years.132 Therefore, based on this 
accumulation of literature, there is reason to believe that, similar to other physical health 
indicators, disparities in muscle weakness may be exist across racial/ethnic groups, even though 
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the measurement of muscle weakness has not been specifically examined in non-white 
populations 45.  
1.12 Summary 
Given the background presented above, this dissertation will chart new territory in 
addressing many of the gaps that currently exist in the muscle health literature with respect to the 
measurement, health outcomes and life course determinants of muscle weakness in older adults. 
First, while major progress has been made in identifying muscle weakness as a key determinant 
of the aging process, there is an ongoing debate as to how to define muscle weakness at the 
population in identifying those most at risk for declines in muscle strength in older age. 
Additionally, much of the work that has been previously conducted has been done in all-white 
samples and used non-nationally representative data population level data that does not reflect 
the growing diversity of older adults in the United States. Therefore, the first aim of this 
dissertation seeks to establish cutpoints for clinical muscle weakness at the population level 
using a racially/ethnically diverse and nationally representative dataset of older American adults. 
 Second, once we have established race/sex specific cutpoints for clinical weakness, the 
second aim of this dissertation will examine the health consequences of muscle weakness in a 
nationally representative and diverse sample of older adults. While few studies have examined 
the longitudinal outcomes of muscle weakness in large scale, epidemiologic setting, we will use 
cutpoints derived in a nationally representative, diverse sample to examine long term risk to 
disability and mortality. Specifically, we are interested in understanding whether weak 
individuals at baseline are at an increased risk of changes in their disability status (Aim 2A) and 
early mortality (Aim 2B) based on the cutpoints established in aim 1.  
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Lastly, given the compelling literature that exists demonstrating the important role early 
and midlife social experiences, specifically that of stressful and traumatic life events, play in 
predisposing individuals to physical health deficits in later life, the third aim of this dissertation 
seeks to understand stress and trauma experienced across the life course may influence 
trajectories of muscle weakness in older adults. 
1.13 Specific Aims and Hypotheses 
The specific aims and hypotheses for this dissertation are as follows: 
Aim 1: To establish race- and sex-specific cutpoints of grip strength from a nationally-
representative, racially-diverse sample of Americans aged 65 years and older, and to estimate the 
race-sex specific prevalence of muscle weakness.  
Hypothesis 1: We hypothesize that grip strength cutpoints in nationally representative 
data may be lower because of the greater likelihood of chronic health problems and 
disability in a heterogeneous national sample. 
Aim 2: To examine the predictive ability of our cutpoints in quantifying the association between 
baseline muscle weakness and physical disability and mortality in a nationally representative 
sample, diverse sample of older Americans.   
Hypothesis 2a: We hypothesize that individuals who are weak at baseline, as identified by 
our previously defined subgroup specific cutpoints (see Aim 1), will be at greater odds of 
experiencing physical disability onset and progression across the 2-year time period 
compared to non-weak individuals. 
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Hypothesis 2b: We hypothesize that individuals who are weak at baseline, as identified by 
our previously defined subgroup specific cutpoints, will be more likely to die earlier 
compared to non-weak individuals, even after accounting for time-varying confounders. 
 
Aim 3: To identify the whether life course stress and trauma is associated with grip strength 
trajectories in a nationally representative sample older Americans and to examine whether the 
timing of stressful and traumatic events experienced at distinct life stages is associated with 
changes in grip strength over time.  
Hypothesis 3a: Individuals who experience greater stress and trauma will undergo 
steeper declines in muscle strength in older age compared to those who experience none 
or fewer stressful and traumatic events.  
Hypothesis 3b: Greater accumulation of stressful and traumatic events across the life 
course will be associated with steeper declines in grip strength trajectories in older age, 
compared to experiencing these events at a critical life stage.
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CHAPTER 2.  Cutpoints for Clinical Muscle Weakness Among Older Americans 
2.1 Abstract 
Background: Muscle weakness is an important indicator of disability, chronic disease and early 
mortality. Grip strength is a simple, cost-effective measure of overall muscle strength. The 
Foundation of the National Institutes of Health (FNIH) recently proposed sex-specific grip 
strength cutpoints for clinical muscle weakness. However, these criteria were established using 
non-nationally representative data. The objective of this study was to use nationally 
representative data on Americans age 65+ to identify race and sex-specific cutpoints for clinical 
muscle weakness and quantify the prevalence among older Blacks and Whites by sex. 
Methods: Classification and Regression Tree (CART) models were used to identify cutpoints 
based on individual-level grip strength associated with slow gait speed (<0.8 m/s) among 7,688 
individuals (57% female, 8% Black, mean age= 74.6±6.79 years) from the 2010/2012 Health and 
Retirement Study during January-April 2016. Identified cutpoints were then used to quantify the 
prevalence of weakness by race/sex sub-group. 
Results:  Fifty-five percent of men (max grip strength <39kg) and 47% of women (<22kg) were 
classified as weak. Higher cutpoints were identified for Black males (<40kg) and females 
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(<31kg), and the prevalence of weakness (57% and 88%, respectively), was higher compared to 
Whites. Fifty-five percent of individuals had slow gait speed (<0.8 m/s). 
Conclusions:  Prevalence of weakness was substantially higher than previous reports, 
underscoring the importance of using population level data to identify individuals at greatest risk 
for adverse health outcomes. This is the first study to establish cutpoints for muscle weakness in 
a nationally representative sample by race and sex. 
 
2.2 Introduction 
  Muscle weakness is a primary determinant of age-related loss of function, 22,23  
and is associated with mobility disability, 14,24,25cardiovascular disease26  and mortality 26,27.  
Hand grip strength has been shown to be a reliable and cost-effective surrogate of overall muscle 
strength133,134 and is a robust prognostic indicator of dynapenia, subsequent functional 
limitations14,24 and  future disease status26. Leong et al. found grip strength to be a stronger 
predictor of all-cause and cardiovascular mortality than systolic blood pressure26.  
The current guidelines used to classify older adults as clinically weak were derived from 
grip strength cutpoints developed by the Foundation of the National Institutes of Health (FNIH) 
(25.99 kg for men and 15.92 kg for women)36,37. However, these cutpoints were derived from 
non-nationally representative, pooled data across 8 observational and 6 clinical trial studies that 
do not reflect the growing racial and ethnic diversity in the U.S. population37. The primary 
objectives of the current study were to establish race- and sex-specific cutpoints of grip strength 
from a nationally-representative, racially-diverse sample of Americans aged 65 years and older, 
and to estimate the race-sex specific prevalence of muscle weakness. We hypothesize that grip 
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strength cutpoints in nationally representative data may be lower because of the greater 
likelihood of chronic health problems and disability in a heterogeneous national sample 24,135. 
 
2.3 Methods 
Data come from the Health and Retirement Study (HRS), a nationally-representative, 
multistage area probability survey of non-institutionalized, community dwelling Americans aged 
51 years and older. Study details have been previously described 136. HRS is the longest running 
longitudinal study of older Americans in the United States, with consistent response rates of  
~85% 136. Sampled persons have been re-interviewed biannually since 1992. New cohorts have 
been added to the original sample to maintain the nationally-representative nature of the survey 
over time 136.  
Starting in 2006, a random one-half sample of HRS participants was selected for an 
enhanced face-to-face interview that included physical measurements (gait speed for those 65+ 
and hand grip strength), and the other random one-half completed the same interview in 2008 137. 
Proxy interviews and nursing home residents were ineligible to participate.  
We used the latest cross-sectional waves of HRS data (2010/2012) to identify cutpoints 
for clinical muscle weakness, herein referred to as clinical weakness, in the most recent cohorts 
of older Americans. Our analytic sample is composed of adults aged 65+ in 2010 (n= 4,898) and 
2012 (n= 4,652), creating one cross-sectional dataset (N=9,550). Excluding proxy interviews and 
nursing home residents (n=1,475) as well as those self-reporting as “other” race (n=387), 
resulted in a final analytic sample of 7,688 individuals. 
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The HRS was approved by the Behavioral Sciences Committee institutional review board 
at the University of Michigan. The data used in this analysis are publically available and contain 
no unique identifiers thereby ensuring respondent anonymity.  
Measures 
Hand grip strength 
Hand grip strength was assessed using a Smedley spring-type hand dynamometer (Scandidact, 
Denmark). Participants were instructed to squeeze the device with the dominant hand as hard as 
they could and then let go. Grip strength assessments were administered while participants were 
standing with their arm at their side, with the elbow flexed at a 90 degree angle.137 After one 
practice trial, two measurements were taken with each hand, alternating hands. The maximum 
measurement from the four trials was used for the analysis. 
Timed Walking Test 
Following existing work22,36,37, slow gait speed was used as the primary outcome for calibrating 
grip strength cutpoints for clinical weakness. Gait speed was assessed using a timed walking test 
administered by trained raters in participants’ homes 137. A space of approximately 12 feet in 
length was needed to set up the walking course. Study participants were timed while walking at 
their “normal pace” along an 8-foot course. Participants were permitted to use a walking aid if 
they normally used one to walk. The interviewer stopped the time as soon as the participant’s 
foot was completely past the tape marking the finish line and flat on the floor. Two trials were 
administered and the average of the two times was used to create a measure of usual gait speed 
(meters per second (m/sec)). A binary indicator of slow gait speed was created based on a 
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walking speed of less than 0.8 m/sec, which is highly predictive of incident disability138 and 
mortality in both blacks and whites 139.  
Missing data for gait speed (n=832) (for those with recent surgeries, injuries, or other health 
conditions (n=125), feeling unsafe (n=222), or not having suitable space for the test (n= 283)) 
were imputed using the multiple imputation methods in SAS 9.3 (PROC MI) with standard error 
corrections performed using PROC MIANALYZE 140.  
Covariates  
 We included all relevant covariates that the FNIH included in their models in order to replicate 
their study as closely as possible,37  including age, sex, self-reported race/ethnicity, number of 
chronic conditions (a three-level summary score based on having less than, at least one, or more 
than one self-reported medically diagnosed chronic health condition, e.g. arthritis, diabetes, heart 
condition), and body mass index (BMI) (weight in kilograms/(height in meters)2).  
Activities of Daily Living 
Diagnostic properties of the grip strength cutpoints were assessed by quantifying the 
sensitivity and specificity of weakness corresponding to two clinically important outcomes: slow 
gait speed and difficulty with activities of daily living (ADLs) 141,142. ADL disability was 
assessed using self-reported difficulty with six self-care activities of daily living (eating, bathing, 
dressing, transferring, toileting and walking across a room) 143. For each activity, difficulty was 
recorded as present (i.e., difficulty with activity or cannot do at all) or absent (no difficulty). A 
dichotomous variable was created to identify participants that reported difficulty with one or 
more activities versus none. 
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Statistical Analysis 
Analyses were conducted from January-April 2016. Classification and Regression Tree 
(CART) models were used to identify grip strength cutpoints for clinical weakness that were 
associated with slow gait speed (<0.8m/sec). CART models recursively partition data to identify 
those predictors with the strongest relationship with the outcome based on the criterion of 
minimum prediction error.144,145 Candidate predictors entered into the model included: (1) 
maximum grip strength, (2) number of chronic conditions, (3) age, and (4) BMI. Individual 
models were run for each sex-race group. In order to avoid over fitting, cross-validation was 
employed for each of the sex and race specific trees by randomly partitioning the data into 10 
mutually exclusive datasets. Each fully-grown tree was then applied to each of the subsamples 
where the error variance was obtained. All trees were then pruned based on established 
recommendations 144 to yield a final set of sex and race specific grip strength cutpoints.  
All statistical analyses were conducted using SAS 9.3140 and R version 3.1.2 using the rpart 
package144. Differences between individuals who were weak versus non-weak were assessed 
using t-tests for continuous variables and chi-squared tests for categorical variables. Descriptive 
analyses were weighted using HRS sampling weights and statistical significance was assessed 
with a two-tailed alpha of 0.05 
2.4 Results 
The age, sex and race breakdown of the sample is consistent with that of Americans aged 65 
years and older based on 2012 U.S. census data.143 Table 2.1 presents the weighted socio-
demographic characteristics for all study participants. Fifty-seven percent were women, 91% 
were White, and the mean age was 75.2 years (range 65-100 years).  
---- Table 2.1 ---- 
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Men had a higher overall mean grip strength (39 kg) compared to women (22 kg) (p<0.001). 
Black women had significantly higher mean grip strength (24.5 kg) compared to White women 
(22.1 kg) (p<0.001); however, no differences were found between Black and White men. Slow 
gait speed was highly prevalent in this national sample, with over 55% walking slower than 0.8 
m/sec. Among Whites, 44% of men and 58% of women had slow gait speed, compared to 75% 
percent of Black men and 87% of Black women.  
 
After running sex-specific CART models, a primary split was on race was identified, indicating 
that grip strength cutpoints may differ across subgroups. As a result, subgroup specific models 
for black men, black women, white men, and white women were run. Results from the CART 
models indicate that grip strength had the greatest predictive power of slow gait speed, appearing 
as the primary split in all models. The cutpoints and prevalence estimates by sex are presented in 
Table 2.2, along with the published cutpoints by FNIH 37 for comparison. Based on the HRS 
cutpoints, over half of this nationally representative sample of men and women (55% of all men 
(<39kg) and 47% of all women (<22kg)) were classified as weak, compared to 10% and 12% for 
men (<25.99 kg) and women (<15.92 kg), respectively, using the FNIH cutpoints. Cutpoints for 
clinical muscle weakness based on a walking speed of 0.6 m/sec are provided as a supplementary 
table (Supplementary Table 2.4).  
---- Table 2.2 ---- 
Results from the CART models and associated prevalence estimates for the sex/race specific 
subgroups are presented in Table 2.3. Among Whites, 37% of men (<35kg) and 48% of women 
(<22kg) were considered weak; whereas among Blacks, 57% of men (<40kg) and 88% of 
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women (<31kg) were categorized as weak. A visual representation of each CART tree is 
presented in Figure 2.1. 
---- Figure 2.1 ---- 
---- Table 2.3 ---- 
The HRS grip strength cutpoints were found to have moderately high sensitivity and specificity 
with respect to slow gait speed and ADL disability (Supplementary Table 2.5). For slow gait 
speed, sensitivity of the weakness cutpoints was 75% and 60% for white men and women, 
respectively. Specificity was also moderately high for white women (68%) and moderate for 
white men (54%). Sensitivity for Black men (69%) and Black women (90%) was notably higher, 
while specificity was somewhat lower for Black men (65%) and women (29%). When 
comparing individuals on both weakness and ADLs, moderately high sensitivity and moderate 
specificity values for all subgroups were identified, providing further support that grip strength 
cutpoints were consistently identifying individuals with impaired function 
2.5  Discussion 
This is the first study to identify grip strength cutpoints for clinical weakness using 
nationally-representative data for older Americans. Findings indicate that muscle weakness is 
highly prevalent in the population, affecting over half of men and women age 65+, and cutpoints 
varied widely by sex and race.  
While there has been an ongoing debate in the literature on the validity of different 
cutpoints for clinical weakness,21 the FNIH cutpoints were intended for clinical practice36 and are 
already being utilized in research 49,50. The identified FNIH thresholds for grip strength are 
markedly lower than those we obtained using population-based data, despite replicating their 
analysis using the same outcome (gait speed <0.8 m/sec) with CART models. When quantifying 
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the prevalence of clinical weakness using the FNIH cutpoints for men (<25.99kg) and women 
(<15.92kg) in the HRS data, only 10% of men and 12% of women were classified as weak. 
Using the FNIH cutpoints may, therefore, only identify the weakest and frail individuals in the 
population.  
There is always a trade-off between sensitivity and specificity when cut-points are 
assigned to a continuous screening variable. However, from a public health and prevention 
perspective, the choice to utilize a more conservative cut-point may misclassify a large 
percentage of people who are actually at risk for future adverse health outcomes. We argue that it 
is far better to screen aggressively and provide early opportunities for identifying individuals that 
might actually benefit from a targeted intervention to delay and/or prevent steeper declines in 
function and health. 
The grip strength cutpoints we obtained for White men and women are consistent with a 
recent population-based survey in Finland, in which the association between grip strength 
cutpoints (<37kg in men and <22kg in women) and future incident mobility limitations was 
examined.24 Similarly, research conducted by Cruz-Jentoft et al. found that among community 
dwelling older adults in Italy, having a grip strength <30kg in men and <20kg in women was 
associated with slow gait speed and an inability to walk 1 kilometer without difficulty.22  
We found that grip strength cutpoints varied markedly by race, resulting in substantial 
differences in the prevalence of weakness by race and sex. Compared to White men (<35kg) and 
women (<22kg), grip strength cutpoints for clinical weakness were higher for Black men 
(<40kg) and women (<31kg), indicating slow gait speed at higher levels of muscle strength. The 
accumulation of risks across the life course 146,147 may offset the strength advantage in Blacks. In 
addition, other competing risks may partly explain the high prevalence of slow walking speed in 
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Blacks.  Notably, 44% of Black women and 33% of Black men were obese in our study, and 
weight status has been found to be an important predictor of slow walking speed.148 Thus, 
muscle strength may not confer the same level of protection for functional health outcomes in 
obese individuals. However, we found similar results when using relative grip strength (grip 
strength/BMI) in our CART models.  
The results presented in this study are the first to address a critically important and stark 
health disparity among older Black Americans, a minority group that has been largely 
overlooked in the muscle weakness literature, despite being at greater risk for physical 
functioning deficits and disability in later life.130 This work moves the field forward in 
identifying race-specific cutpoints while simultaneously shedding light on emerging health 
disparities that, if left untreated, may lead to a disproportionate burden of disability among 
Blacks. 
Strengths/Limitations 
This study has several notable strengths. First, we used a novel statistical method in a 
nationally-representative sample to obtain sex-specific cutpoints of clinical weakness by race. 
Although CART has been used in clinical research, tree-based approaches have been largely 
underutilized within observational epidemiology149,150. While variations in body composition 
across racial and ethnic groups are well established 37, this is the first study to examine  racial 
differences in muscle weakness in diverse sample of older American adults. In addition, using 
nationally representative data is an important strength of our study because the results can be 
generalized to American adults aged 65 years and older, rather than a select few. Given the 
emerging burden of weakness at the population level, the use of nationally representative data 
provides a critical first step in screening efforts used to identify individuals who may be a 
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greatest risk, and ultimately for determining where best to direct preventive interventions. 
Previous work has derived cutpoints from sample-specific distributions,22 and relied on non-
representative reference populations,24,31 or non-nationally representative, pooled data sources to 
establish definitions for weakness37, all of which may not be generalizable at the population level 
for identifying and treating clinical weakness.   
Despite these strengths, this study is not without limitations. We did not have enough 
power to explore muscle weakness cutpoints by other racial/ethnic groups. Future work is needed 
to examine grip strength cutpoints for older Hispanics since this is a rapidly growing subgroup 
projected to increase by nearly 115% between 2014 and 2060 in the U.S.152 Given the cross-
sectional nature of this analysis, the temporal relationship between grip strength and gait speed 
could not be established. Longitudinal data are needed in order to directly assess the directional 
link between strength loss and mobility impairment, and to test whether clinical weakness at 
baseline predicts negative health outcomes in later life. The timed walk was assessed by trained 
interviewers using home-based measurements that may be subject to measurement error. 
However, when using a more conservative criterion of 0.6 m/sec for slow gait speed,153 we found 
that 29% of men and 22% of women were classified as weak, which is still greater than twice the 
prevalence identified using the FNIH cutpoints37.  Despite substantial evidence documenting the 
utility of walking speed as a robust determinant of future health risk,139,154,155 the slow walking 
speed cutpoint may penalize individuals who are overweight or obese. That is, because 
overweight individuals have more mass to move, they are more likely to be deemed “slow” 
walkers. While having extra fat mass is an independent risk factor for many negative health 
outcomes, in using the slow walking variable as the key calibrating variable in defining 
weakness, there is an implicit assumption that slow walkers are inevitably weak, which may not 
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be the case. Thus, using the slow walking speed cutpoint in defining weakness may be especially 
problematic since, in our sample, 72% and 78% of Black men and women, respectively, were 
overweight/obese. Future research should explore other calibrating variables in defining muscle 
weakness in a diverse setting. Lastly, one major driver of sarcopenia is the subsequent loss in 
muscle mass12. We were unable to assess appendicular muscle mass because body composition 
measurements were not available in HRS. 
2.6 Conclusions 
The cutpoints established in this study can serve as an easy and accessible clinical tool 
for identifying individuals who may be at risk for experiencing adverse health outcomes, 
including future falls,156 incident disability,14,24 morbidity 26 and all-cause mortality.26,27 Early 
identification of those at risk provides the greatest opportunities for effective interventions (e.g., 
resistance training) aimed at increasing muscle strength. We observed a high prevalence of both 
weakness and slow gait speed in older Americans, which considered concurrently, have 
important implications for future disability risk in the US population. Our results underscore the 
importance of using population level data to identify individuals at greatest risk for adverse 
health outcomes.
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2.7 Tables & Figures 
Table 2. 1 Demographic Characteristics of Study Sample by Race and Sex: Health and retirement Study age 65+ (n=7,688).  
 
Whites (n= 6,628) 
 
Blacks (n= 1,058) 
 
Men  
(n= 2,799)   
Women 
(n= 3,829)   
Men 
(n=383)   
Women 
(n=675)  
Variables Mean (SD)  Mean (SD)   Mean (SD)  
Mean 
(SD)  
Age (y) 75.5 (6.7)  75.4 (7.0)  73.6 (5.8)  73.9 (6.2) 
Maximum Grip Strength (kg) 37.8 (8.7)  22.1 (5.7)  37.2 (8.7)  24.5 (5.8) 
Gait Speed (meters/second)  0.83 (.25)  .75 (.25)  .67 (.21)  .59 (.21) 
        
 
Na (%)b    N (%)   N (%)   N (%) 
Slow Walking Speed        
Slow Walkers (<.8 m/s) 1297 (44.0)  2249 (58.7)  287 (74.9)  
582 
(87.3) 
Normal Walkers (≥.8 m/s) 1502 (56.0)  1580 (41.4)  96 (25.1)  93 (12.7) 
Body Mass Index 
       Underweight (<18.5) 19 (.7)  89 (2.1)  7 (1.4)  10 (2.4) 
Normal Weight (18.5-24.9) 688 (23.5)  1319 (35.7)  100 (27)  
129 
(19.8) 
Overweight (25-29.9) 1253 (45.1)  1289 (34.3)  151 (38.7)  
228 
(33.3) 
Obese (≥30) 830 (30.7)  1067 (28.3)  123 (32.9)  
303 
(44.6) 
Activities of Daily Living (ADLs) 
       
0 2289 (85.8)  3175 (81.7)  317 (79.7)  
490 
(67.2) 
1+  410 (14.2)  654 (18.3)  66 (20.3)  
185 
(32.8) 
Chronic Conditions 
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No chronic conditions 178 (7.2)  212 (5.7)  21 (6.1)  17 (2.5) At least one chronic 
condition 479 (18.0)  678 (18.0)  68 (18.2)  85 (13.3) 
2+ more chronic conditions  2141 (74.7)  2939 (76.2)  294 (75.7)  
573 
(84.1) 
        a Number of participants, unweighted 
       b Percentage, weighted 
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 Table 2. 2 Comparing Grip Strength Cutpoints for Muscle Weakness and Prevalence Estimates by Sex between the HRS AND FNIH. 
  HRS 
 
All Men 
(n=3,182)  
All Women 
(n=4,506)     
Classification Cutpoint (kg)  
N 
(%)*  Cutpoint (kg)  N (%)
a 
Weak <39  
1845 
(55) 
 
<22  1998 (47) 
Normal ≥39   
1274 
(45)   ≥22   2317 (53) 
        
          FNIH 
 
All Men  All Women 
Classification Cutpoint (kg)  
N 
(%)*  Cutpoint (kg)  N (%)* 
Weak <25.99  
317 
(10)  <15.92  523 (12) 
Intermediate ≥25.99  
554 
(17)  ≥15.92  863 (20) 
Normal ≥31.83   
2248 
(73)   ≥19.99   2929 (68) 
 
a Weighted percentages 
     
  
 
 
 38 
Table 2. 3 Cutpoints and Prevalence Estimates for Clinical Muscle Weakness by Race/Sex in the Health and Retirement Study. 
 
 
 
HRS Total Sample (N= 7,688) 
  
White Males   Black Males  White Women  Black Women 
  
(n=2,799)  (n=383)  (n=3,829)  (n=675) 
 
Classification Cutpoint (kg)  
N 
(%)  
Cutpoint 
(kg)  N (%)  
Cutpoint 
(kg)  N (%)  
Cutpoint 
(kg)  N (%) 
 
Weak <35  
1111 
(37)  <40  
223 
(57)  <22  
1794 
(48)  <31  
557 
(88) 
 
Normal ≥35  
1639 
(63)  ≥40  
145 
(43)  ≥22  
1885 
(52)  ≥31  78 (12) 
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Figure 2. 1 Classification and regression trees for clinical muscle weakness by race/sex in the Health and Retirement Study. 
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Table 2. 4 Cutpoints and Prevalence Estimates for Clinical Muscle Weakness by race/sex in the Health and Retirement Study (walking 
speed <.6 meters/second). 
HRS Total Sample (N= 7,688) 
 
White Males   Black Males  White Women  Black Women 
 
(n=2,799)  (n=383)  (n=3,829)  (n=675) 
Classification 
Cutpoint 
(kg)  N (%)  
Cutpoint 
(kg)  N (%)  
Cutpoint 
(kg)  N (%)  
Cutpoint 
(kg)  N (%) 
Weak  <31  675 (25) 
 
<39  
213 
(58) 
 
<18  792 (22) 
 
<25  
318 
(50) 
Normal ≥31   
2075 
(75)   ≥39   
155 
(42)   ≥18   
2887 
(78)   ≥25   
317 
(50) 
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Table 2. 5 Diagnostic properties for Grip Strength Cutpoints in the Prediction of Slow Walking Speed and Activities of Daily 
Living (ADL) in the Health and Retirement Study.  
Slow Walking Speed (<.8 m/s) 
 White Males (n=2,750)   
Black Males (n=368) 
 
Slow Walking Speed 
  
Slow Walking Speed 
Weak 
 
Yes No 
  
Weak 
 
Yes No 
 Yes 953 678 1631  Yes 190 33 223 
No 315 804 1119  No 84 61 145 
 
1268 1482 2750   
274 94 368 
 
Sensitivity 75.16 
 
 
 
Sensitivity 69.34 
 
Specificity 54.25 
 
Specificity 64.89 
            White Females (n=3,679)   
Black Females (n=635) 
 
Slow Walking Speed 
  
Slow Walking Speed 
Weak 
 
Yes No 
  
Weak 
 
Yes No 
 Yes 1296 498 1794  Yes 494 63 557 
No 847 1038 1885  No 52 26 78 
 
2143 1536 3679   
546 89 635 
 
Sensitivity 60.48 
 
 
 
Sensitivity 90.48 
 
Specificity 67.58 
 
Specificity 29.21 
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Activities of Daily Living ( 0 vs. 1+) 
 White Males   
Black Males 
 
ADLs (1+ vs. 0) 
  
ADLs (1+ vs. 0) 
Weak 
 
Yes No 
  
Weak 
 
Yes No 
 Yes 288 1343 1631  Yes 45 178 223 
No 104 1015 1119  No 16 129 145 
 
392 2358 2750   
61 307 368 
 
Sensitivity 73.47 
 
 
 
Sensitivity 73.77 
 
Specificity 43.04 
 
Specificity 42.02 
            White Females   
Black Females 
 
ADLs (1+ vs. 0) 
  
ADLs (1+ vs. 0) 
Weak 
 
1 0 
  
Weak 
 
1 0 
 Yes 400 1394 1794  Yes 159 398 557 
No 186 1699 1885  No 9 69 78 
 
586 3093 3679   
168 467 635 
 
Sensitivity 68.26 
 
 
 
Sensitivity 94.64 
 
Specificity 54.93 
 
Specificity 14.78 
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CHAPTER 3. Chapter 3. Muscle Weakness And Physical Disability In Older Americans: 
Longitudinal Findings From The U.S. Health And Retirement Study 
3.1 Abstract  
Importance: Muscle weakness is an important indicator of disability, chronic disease and 
mortality. While we recently proposed sex/race specific grip strength cutpoints for clinical 
muscle weakness in a diverse, nationally representative sample of older Americans, the extent to 
which these cutpoints predict physical disability remains unknown.  
Objective: To examine whether sex/race specific muscle weakness cutpoints predict physical 
disability status in a nationally representative sample of Americans age 65+. 
Design: We used data from the 2006-2010 Health and Retirement Study. Fully-adjusted, 
weighted multinomial logistic regression models were used to quantify the odds of experiencing 
the onset, progression or persistence of disability in activities of daily living (ADL) among weak 
versus non-weak individuals over a 2-year period.  
Setting: General community, nationally representative sample of older Americans 
Participants: Population-based, community dwelling sample of older American adults aged 65-
years+; 57 percent were women, 91% were White and the mean age was 75 years. 
Main Outcome(s) and Measure(s): The primary outcome of interest was disability dynamics, 
defined by changes in ADL status across at 2- year period. The primary exposure was clinical 
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muscle weakness as defined by previously identified cutpoints. Hypotheses were formulated 
before analyses were conducted. 
Results: In this nationally representative sample (n= 8,725), 44% of individuals were classified 
as weak at baseline. At follow-up, 55% remained independent with no change in their ADL 
status, 11% had an onset of disability and 4% progressed in their disability status. The odds of 
experiencing an onset of ADL disability was 54% higher among weak individuals compared 
those who were not weak at baseline (OR= 1.54, 95% CI= 1.54, 1.5, p<.0001); the odds of 
experiencing a progression in physical disability status was 2.16 times higher among those who 
were weak at baseline compared to non-weak individuals (OR= 2.16, 95% CI= 2.15, 2.16, 
p<.0001).  
Conclusions: This is the first study to use grip strength weakness cut-points to identify those 
who may be at greatest risk for experiencing physical disability in later life. Results underscore 
the importance of using population-specific cutpoints for clinical weakness in order to identify 
individuals at greatest risk for adverse health outcomes.  
 
3.2 Introduction 
Muscle weakness is a primary determinant of age-related loss of function, 22,23  and is 
associated with mobility disability, 14,24,25 cardiovascular disease26  and early mortality.26,27 Hand 
grip strength has been shown to be a reliable and cost-effective surrogate of overall muscle 
strength16,157 and is a robust prognostic indicator of subsequent functional limitations14,24 and  
future disease status26. While age-related losses in muscle strength and mass are a natural part of 
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the aging process, individuals who undergo steeper declines in muscle strength may be more 
vulnerable to changes in physical disability status in later life. 14,41,67 
Despite a well-documented literature linking muscle weakness to disability14,41,70,158 and a 
host of other negative health outcomes,26,42,159 an ongoing debate remains regarding how best to 
define muscle weakness in a clinical setting. Recent efforts to define clinical muscle weakness 
proposed by the Foundation for the National Institutes of Health were derived using non-
nationally representative, pooled data that do not reflect the growing racial and ethnic diversity 
in the U.S. population.37 As a result, we recently established cutpoints for clinical muscle 
weakness (Table 3.1) in a nationally-representative, racially-diverse cross-sectional sample of 
Americans aged 65 years and older.160 and found a higher prevalence, where 55% of men (max 
grip strength <39kg) and 47% of women (max grip strength <22kg) were clinically weak. In 
addition, we identified stark race/ethnicity disparities, with 57% of Black men (<40kg) and 88% 
of Black women (<31kg) were considered to have clinical muscle weakness compared to 37% 
and 48% of White men and women, respectively. While these data represent an important step 
forward in defining muscle weakness at the population level, it is still not known whether these 
cutpoints can be used to predict subsequent changes in disability status over time. Understanding 
disability dynamics is an important health outcome that has significant implications for the 
rapidly aging US older adult population. 
---- Table 3.1 ---- 
Therefore, in order to address these gaps, the primary objectives of this study were to 
examine the predictive ability of the population-based cutpoints for clinical muscle weakness, 
and to quantify the association between baseline muscle weakness and the onset, progression and 
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persistence of physical disability in a nationally-representative sample of older Americans during 
a 2-year time period.  We hypothesize that older adults that are strong at baseline, as identified 
by previously defined sex/race specific cutpoints, will be at reduced odds of experiencing onset, 
progression and persistence of disability and more likely to improve across a 2-year time period, 
compared to weak individuals. 
3.3 Methods 
Design and Sample Population 
Data come from the Health and Retirement Study (HRS), a nationally-representative, 
multistage area probability survey of non-institutionalized, community dwelling Americans aged 
51 years and older. Study details have been previously described 136. HRS is the longest running 
longitudinal study of older Americans in the United States, with consistent response rates of  
~85%.136 Sampled persons have been re-interviewed biannually since 1992, and new cohorts 
have been added to the original sample to maintain the nationally-representative nature of the 
survey over time.136 Ongoing surveillance via the National Death Index provide continuous 
mortality status, including date of death, for all participants.  
In 2006, half the sample of HRS participants was randomly selected for an enhanced 
face-to-face interview that included physical measurements (gait speed for those 65+ and hand 
grip strength), and the other random one-half completed the same interview in 2008.137 The 2006 
and 2008 random sub-samples were then combined to yield the full, eligible baseline sample. 
Proxy interviews and nursing home residents were ineligible to participate.  
Individuals who made up the 2006 (n= 5,809) and 2008 (n= 5,542) HRS waves were 
combined to yield a full baseline sample of 11,351 eligible individuals. We subsequently 
 
 
 47 
excluded individuals who were less 65 years of age (n=7,832), identified as “other” race 
(n=393), and those who required a proxy interview or were in a nursing home at the time of the 
interview (n=2,167). After applying these exclusion criteria, our final analytic sample was 
composed of 8,725 individuals. Two-year follow-up data were included for all individuals from 
2008 and 2010. 
Measures 
Hand grip strength 
Hand grip strength was assessed using a Smedley spring-type hand dynamometer 
(Scandidact, Denmark). Participants were instructed to squeeze the device with the dominant 
hand as hard as they could, and then let go. Grip strength assessments were administered while 
participants were standing with their arm at their side, and with the elbow flexed at a 90 degree 
angle.137 After one practice trial, two measurements were taken with each hand, alternating 
hands. The maximum measurement from the four trials was used for the analysis. HRS sub-
group specific cutpoints for clinical weakness were then applied to identify those who were weak 
versus not weak at baseline160. The cutpoints are summarized in Table 3.1.  
Physical Disability 
Physical disability was assessed using self-reported difficulty with six self-care activities 
of daily living (ADLs): eating, bathing, dressing, transferring, toileting and walking across a 
room.143 For each activity, difficulty was recorded as present (i.e., difficulty with activity or 
cannot/does not do) or absent (no difficulty). An ADL summary score was computed for each 
individual based on the sum of all reported difficulties across all 6 activities. For example, if an 
individual reported 3 ADL difficulties, then they received an ADL summary score of 3. Two 
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ADL summary scores were calculated for each individual—one at baseline (2006/2008) and then 
at follow-up 2 years later (2008/2010).  
In order to assess changes in physical disability status across the 2-year period, an ADL 
change score was calculated as the difference between the ADL summary score at follow-up and 
baseline. After creating the ADL change score for each person, a 6-level outcome variable was 
created based on the six types of change observed across the entire sample: (1) “No Disability, 
No Change”, no ADL difficulties reported at both baseline and follow-up; (2) “Persistent 
disability”, individuals reporting the same number of ADL difficulties at baseline and at follow-
up; (3) “Onset”, individuals who reported no ADL difficulties at baseline and at least one or 
more ADL difficulties at follow-up; (4) “Progression”, one ADL difficulty at baseline and more 
than one ADL difficulty at follow-up, (5) “Improvement”, individuals who reported at least one 
ADL difficulty at baseline and at least one fewer ADL difficulty at follow-up; and (6) “Lost to 
follow-up”, individuals who received an ADL score at baseline but were lost to follow-up 
(including mortality) 2 years later. This last group (n=938) was included in order to account for 
missingness and to avoid biasing the analysis, which could occur if these individuals were 
excluded. The “No Disability, No Change” group served as the reference group in the analysis 
since this group had the best outcome and the highest level of functioning. 
Covariates  
The following relevant baseline covariates were included in our model: age (continuous), 
sex, self-reported race/ethnicity, education (3-level categorical variable, less than a high school 
degree, high school degree, some college/college degree), number of chronic conditions 
(continuous summary measure, based on 8 self-reported medically diagnosed chronic health 
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condition: high blood pressure, diabetes, cancer, lung disease, heart disease, stroke, psychiatric 
problems and arthritis), body mass index (BMI) ((measured weight in kilograms/ (measured 
height in meters)2), and gait speed (continuous measure, assessed using a 8-foot long timed 
walking test administered by trained raters in participants’ homes over).137   
Statistical Analysis 
 All statistical analyses were conducted using SAS software 9.3 (Cary, NC).140 Bivariate 
differences between individuals who were weak versus non-weak were assessed using t-tests for 
continuous variables and chi-squared tests for categorical variables. Descriptive analyses were 
weighted using HRS sampling weights and statistical significance was assessed with a two-tailed 
alpha of 0.05. Fully-adjusted models (including age, sex, self-reported race/ethnicity, education, 
number of chronic conditions, BMI, and gait speed), weighted multinomial logistic regression 
models were used to quantify the odds of experiencing an onset or progression in ADL disability 
status among weak versus non-weak individuals, over a 2-year period. Interactions by sex were 
also examined with a 2-level interaction term in the fully-adjusted model. 
3.4 Results 
The age, sex and race breakdown of our sample is consistent with that of Americans aged 
65 years and older based on U.S. census data.143 Table 3.2 presents the weighted socio-
demographic characteristics for all study participants. Fifty-seven percent were women, 91% 
were White, and the mean age was 75 years. Forty-four percent of individuals were identified as 
weak based on the previously identified sub-group specific cutpoints. There was a high 
prevalence of slow walking speed (<0.8 meters/second) with 60 percent of individuals classified 
as slow. At baseline, 80% of individuals had no difficulty with any ADLs. Over the 2-year 
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follow up period the majority of the sample (55%) remained independent with no change in their 
ADL status, 11% had an onset of disability and 4% progressed in their disability status. Six 
percent of the sample improved and 21% of individuals were lost to follow up (678 individuals 
died and 265 were lost due to sample attrition (i.e., unable to locate, refusals) across the 2-year 
follow-up window). Table 3.3 presents the results from the adjusted multinomial logistic 
regression, which assessed the odds of experiencing a change in physical disability status across 
the 2-year follow-up period (2008/2010) compared to the “No Disability, No Change” reference 
group.  
--- Table 3.2 --- 
--- Table 3.3--- 
Disability Onset Versus No Disability, No Change 
Compared to the “No Disability, No Change” reference group, the odds of experiencing 
an onset of physical disability was higher among weak individuals compared to non-weak 
individuals (OR= 1.54, 95% CI= 1.54, 1.55) (Model A, Table 3.3). Females were at greater odds 
of experiencing disability onset (OR= 1.04, 95% CI= 1.04, 1.05) compared to males. Individuals 
with less than a high school degree (OR= 1.17, 95% CI= 1.16, 1.17) or had only a high school 
degree (OR= 1.50, 95% CI= 1.50, 1.51) were at greater odds of disability onset compared to 
individuals with some college or a college degree. Blacks were at greater odds of disability onset 
compared to Whites across the two-year period (OR=1.12, 95% CI= 1.11, 1.12), net of 
covariates.  
Disability Progression versus No Disability, No Change 
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Compared to the “No Disability, No Change” reference group, the odds of experiencing a 
progression in physical disability were substantially higher among those who were weak at 
baseline compared to non-weak individuals (OR= 2.14, 95% CI= 2.13, 2.15) (Model B, Table 
3.3).  Individuals with less than a high school degree were at greater odds (OR= 1.45, 95% CI= 
1.44, 1.45) of disability progression compared to those with some college or a college degree. 
For each additional chronic condition, individuals had over a 50% higher odds of experiencing a 
progression in their disability status (OR= 1.58, 95% CI= 1.58, 1.58). Blacks were also at greater 
odds of experiencing a progression in their disability status compared to Whites across the two-
year period (OR=1.06, 95% CI= 1.05, 1.06).  
Persistent Disability versus No Disability, No Change 
Weak individuals had almost a two-fold higher odds (OR= 1.90, 95% CI= 1.89, 1.91) of 
experiencing persistent disability across the 2-year period compared to non-weak individuals 
(Model C, Table 3.3). Blacks were at greater odds (OR= 1.18, 95% CI= 1.18, 1.19) of persistent 
disability compared to Whites. Individuals who had less than a high school degree had 18% 
increased odds of persistent disability compared to their college-educated counterparts. For each 
additional chronic condition, the odds of persistent disability increased by almost 50% (OR= 
1.49, 95% CI= 1.49, 1.49). Older age, slower walking speed and higher body mass index were 
also associated with remaining persistently disabled over the observation period (all p<0.01).  
Improved versus No Disability, No Change 
Compared to the “No Disability, No Change” group, the odds of experiencing an improvement in 
physical disability was 63% more likely for weak versus non-weak individuals (OR=1.63, 95% 
CI= 1.63, 1.64) (Model D, Table 3.3).  
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Sex by Weakness Interaction 
 In examining whether the association of muscle weakness and disability status differed 
by sex, we found that muscle weakness was strongly associated with disability status for both 
groups; however, the magnitude of this association was stronger for men compared to women. 
Specifically, among men, compared to the “No Disability, No Change” group, the odds of 
experiencing disability onset was 71% more likely for weak men compared to non-weak men 
(OR= 1.71, 95% CI= 1.71, 1.72); the odds of experiencing disability progression was 3.16 times 
more likely for weak men compared to non-weak men (OR= 3.16, 95% CI= 3.15, 3.18); and, the 
odds of experiencing disability recovery was 2.19 times more likely for weak men compared to 
non-weak men (OR= 2.19, 95% CI= 2.19, 2.20) across the 2-year period. 
Among women, compared to the “No Disability, No Change” group, the odds of 
experiencing disability onset was 38% more likely for weak versus non-weak women (OR= 1.38, 
95% CI= 1.37, 1.38); the odds of experiencing disability progression was 70% more likely for 
weak versus non-weak women (OR= 1.70, 95% CI= 1.69, 1.70); and, the odds of experiencing 
disability recovery was 38% more likely for weak versus non-weak women (OR= 1.38, 95% CI= 
1.37, 1.38) across the 2-year period. There was no effect modification by race/ethnicity. 
3.5 Discussion 
To the best of our knowledge, this is the first nationally-representative study to examine 
the pace of disability onset, progression and persistence in relation to muscle weakness in older 
Americans. Consistent with existing work,14,41,70,161 the results of this study indicate that older 
adults with clinical muscle weakness, as identified by sex/race specific population-derived 
cutpoints,160 are at significantly increased risk of experiencing a deterioration in their ability to 
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engage in basic self-care activities of daily living across a two year time period. Specifically, we 
found that clinical muscle weakness is strongly associated with the onset, progression and 
persistence of physical disability status, highlighting the importance of screening efforts to 
identify those who are most vulnerable to the consequences of clinical muscle weakness as they 
age.  
The results of this study bolster the existing literature by using population-derived 
cutpoints for clinical weakness to demonstrate the consequences of muscle weakness for multiple 
patterns of change in physical functioning among older adults over time. Previous work that has 
sought to measure and define clinical muscle weakness has derived cutpoints from sample-
specific distributions,22 and relied on non-representative reference populations,24,31 or non-
nationally representative, pooled data sources to establish definitions for weakness,37 all of which 
may not be generalizable at the population level for identifying and treating clinical weakness.  
Additionally, by examining the development of disability onset, progression and persistence of 
disability, the results of this study indicate that muscle weakness may in fact influence the pace 
of disability. This has important health implications for older adults since previous research has 
shown that disability onset and progression are associated with increased risk of 
hospitalization,162 institutionalization,163 and mortality.164 Prior work examining the association 
between muscle weakness and disability have typically relied on binary definitions of disability 
status (presence/absence),14,165 which may underestimate the weakness-disability association at 
the population level since disability has been shown to fluctuate over time.96,165–167  
Nonetheless, our results are consistent with others that have examined the link between 
muscle weakness and ADL disability and physical functioning. Rantanen et al. found that low 
hand grip strength among 45-68 year olds was strongly associated with disability status 25 years 
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later.14 Using HRS data, Germain et al. found that tertile-specific low muscle strength was 
associated with higher odds of physical and functional outcomes, although those analyses were 
cross-sectional.68 In a 3-year longitudinal study by Onder et al., higher handgrip strength was 
found to be protective against incident ADL disability.66 Additionally, a 4-year longitudinal 
study found that higher handgrip strength was associated with a reduced risk in the development 
of new functional difficulties, although this analysis was restricted to the oldest old.69 
We also found that the association between muscle weakness and disability was stronger 
for males than females across all levels of the disability outcome. While previous work 
investigating sex differences and disability status has found that females are more likely to be 
disabled in older age 168,169, our findings suggest that other contextual factors may play an 
important role in driving disability status among women. In our sample, we found that women 
had greater chronic disease impairment, less education, as well as lower maximum grip strength 
at baseline. Thus, the attenuated estimates observed for women may reflect a complex array of 
risk factors acquired across the life course that differentially impact the relationship between 
muscle weakness and disability status. 
An unexpected finding was that weak individuals were more likely to improve across the 
2-year time period compared to those who were not weak at baseline. While these results were 
unexpected, previous research has found that the probability of experiencing an improvement in 
physical functioning is inversely related to the severity of the disability.170,171 In our study, 75% 
(n=324) of individuals who experienced an improvement in disability had only 1 ADL limitation 
at baseline, implying that the interventions needed to improve one’s disability status may have 
been more attainable and/or accessible compared to individuals with greater disability severity 
(i.e., 3+ ADL limitations). Additionally, several studies have noted that disability trajectories are 
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fluid and may change over time, especially when studied within a longitudinal design setting 
with closely measured, repeated time points.170  
The term “intermittent disability” has been used in the literature to characterize 
individuals who report disability at one time point but not at subsequent follow up points, 
implying that gains made over short intervals may not be permanent. In a 5-year prospective 
cohort study of community-living older adults, Gill et al. (2006) found that the majority of 
participants experienced at least one episode of intermittent disability and that these episodes 
lasted, on average, about 6 months.167 In our study, we found that 75% (n=324) of the 
individuals who reported 1 ADL disability at baseline went on to report no ADL disability at 
follow-up. However, 42% (n=159) of these same individuals went on to report 1 or more ADL 
disability in the subsequent 2 years period (2010/2012). These results imply that while these 
individuals may have improved in the short-term that may have “relapsed” and become disabled 
two years later. Thus, intermittent disability episodes may partially explain the counterintuitive 
findings with respect to weakness in this study. 
Strengths and Limitations 
Our study is not without limitations. First, this analysis examined the association between 
weakness and disability across a two-year interval. It is possible that other competing events, 
such as acute hospitalization, could partially explain the observed weakness-disability 
association. Second, we were unable to control for underlying conditions (i.e., paresis, 
neuropathy, etc.) that may have led to changes in ones’ disability status. Despite this limitation, 
we were able to account for baseline chronic disease status, which is an important indicator since 
multi-morbidity has been found to be associated with both disability and physical functioning.172 
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Third, while research suggests that muscle strength may be an important risk factor in middle age 
14, the cutpoints utilized in this study were derived in adults aged 65+ years.  There is growing 
interest in the role grip strength may play as a mid-life biomarker of future physical functioning 
and disability since previous research has found that disability rates are increasing among 
middle-aged Americans.173 Therefore, future research should focus on middle age as a 
potentially critical window for screening and intervention. Fourth, the primary outcome was 
assessed as self-reported difficulty in activities of daily living, which may have led to an 
underestimate of the true association if sicker individuals were less likely to report changes in 
their ADL status. Lastly, as in any longitudinal design setting, we had 10% attrition due to losses 
to follow-up. However, we accounted for those lost to follow-up in our multinomial ADL 
outcome variable, which reduced potential bias that would have occurred if we had excluded 
these individuals from our analysis. 
Despite these limitations, this study has several notable strengths. First, we used handgrip 
strength as our primary exposure, which is a cost-effective, reliable proxy for total body muscle 
strength that can be easily administered in the clinical setting 43,174. The results of this study 
imply that the grip strength cutpoints utilized in this study can be used for identifying those 
individuals most at risk for changes in disability status without involving invasive diagnostic 
tools or time-intensive screening questionnaires. Additionally, our findings provide support for 
the prognostic utility of the population-derived muscle weakness cutpoints used in this study, 
which has important implications since screening and intervention efforts cannot be fully 
realized until clinical and epidemiologic communities coalesce around standardized cutpoints to 
identify individuals who may be a greatest risk.  Finally, our results provide support for tailoring 
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interventions to each individual’s unique dynamic disability status in an effort to prevent steeper 
declines as individuals age. 
3.6 Conclusions 
This is the first study to use muscle weakness cut-points derived in a nationally-
representative sample of older Americans to identify those who may be at greatest risk of 
experiencing onset, progression and persistence in their disability status in later life. Results 
underscore the importance of using population-specific cutpoints to identify individuals at 
greatest disability risk. 
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3.7 Tables and Figures 
Table 3. 1 Cutpoints for clinical muscle weakness by race/sex in the Health and Retirement Study. 
2006/2008 HRS Total Sample (N= 8,725) 
 
White Males   Black Males 
 
White Women 
 
Black Women 
 
(n=3,279) 
 
(n=422) 
 
(n=4,286) 
 
(n=738) 
 
Cutpoint (kg) 
 
Cutpoint (kg) 
 
Cutpoint (kg) 
 
Cutpoint (kg) 
Weak  <35 
 
<40 
 
<22 
 
<31 
Normal ≥35  ≥40  ≥22  ≥31 
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Table 3. 2 Demographic characteristics in weak and non-weak older adults, Health and 
Retirement Study, 2006/2008 (N= 8,725). 
 Mean  SD 
Age (y) 74.9  7.1 
Maximum Grip Strength (kg) 29.2  10.4 
Gait Speed (meters/second)  3.9  2.1 
    
 
N*    %** 
   Sex    
               Female 5024  56.8 
   Race/Ethnicity    
White 7565  91.9 
Black 1160  8.1 
Muscle weakness    
Weak 3813  44.3 
Non-weak 4654  55.7 
Activities of Daily Living (ADLs) 
   Independent, no change  5673 
 
55.0 
Persistent 299 
 
2.8 
Onset 233 
 
11.2 
Progression 337 
 
4.2 
Improved 645  5.6 
Lost to follow up 938  21.2 
Slow Walking Speed    
Slow Walkers (<.8 m/s) 5245  60 
Normal Walkers (≥.8 m/s) 3480  40 
Body Mass Index 
   Underweight (<18.5) 142  1.9 
Normal Weight (18.5-24.9) 2734  32.9 
Overweight (25-29.9) 3319  38.0 
Obese (≥30) 2436  21.2 
Chronic Conditions 
   No chronic conditions 673  7.9 
At least one chronic condition 1819  20.8 
2+ more chronic conditions  6232  71.3 
    *Number of participants, unweighted 
   ** Percentage, weighted 
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Table 3. 3 Disability and Muscle Weakness: Multinomial Logistic Regression Models for Disability Status*, Health and Retirement 
Study, 2006/08-2008/10. 
 
A. Disability Onset vs. 
Independent, No 
Change 
B. Disability Progression 
vs. Independent, No 
Change 
C. Disability Persistence 
vs. Independent, No 
Change 
D. Disability Improvement 
vs. Independent, No 
Change 
 
Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI 
Variable 
  
        
  
   
        
  Weak 
  
        
  Non-Weak Ref  Ref   Ref   Ref  Weak 1.54 1.54, 1.55 2.16 2.15, 2.16 1.90 1.89, 1.91 1.64 1.63, 1.64 
Sex             Males Ref  Ref   Ref   Ref  Females 1.04 1.04, 1.05 0.99 0.99, 0.99 0.98 0.98, 0.98 1.30 1.30, 1.31 
Race/Ethnicity             Whites Ref  Ref   Ref   Ref  Blacks 1.12 1.11, 1.12 1.06 1.05, 1.06 1.18 1.18, 1.19 0.99 0.99, 1.00 
Education             Some college/College Ref  Ref   Ref   Ref  High school 1.50 1.5, 151 0.89 0.88, 0.89 1.02 1.01, 1.02 1.00 1.00, 1.01 
Less than high school 1.17 1.16, 1.17 1.45 1.44, 1.45 1.18 1.18, 1.19 1.47 1.47, 1.48 
Chronic conditions 1.42 1.41, 1.42 1.58 1.58, 1.58 1.49 1.49, 1.49 1.54 1.53, 1.54 
Age 1.06 1.05, 1.06 1.05 1.04, 1.05 1.05 1.05, 1.06 1.03 1.03, 1.03 
Walking speed 1.21 1.2, 1.21 1.39 1.39, 1.39 1.31 1.3, 1.31 1.39 1.39, 1.39 
Body Mass Index 1.02 1.02, 1.02 1.07 1.06, 1.07 1.06 1.06, 1.06 1.05 1.05, 1.05 
         *Reference Group: Independent, No Change 
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CHAPTER 4. Do Nationally Representative Cutpoints For Clinical Muscle Weakness 
Predict Mortality? Results From Nine Years Of Follow-Up In The Health And 
Retirement Study 
4.1 Abstract 
Background: Muscle weakness, as measured by handgrip strength, is associated with 
cardiovascular and all cause-mortality; however, there are wide inconsistences in the magnitude 
of these effects due to divergent definitions used to define muscle weakness across studies. 
Therefore, the objective of this study was to examine the relationship between previously defined 
sex/race-specific cutpoints of clinical muscle weakness and early mortality.  
Methods: Data comes from the 2006-2014 Health and Retirement Study. Time-varying clinical 
muscle weakness, as defined by handgrip strength cutpoints, was the primary exposure. Time to 
death, ascertained from the National Death Index, was the outcome of interest. The association 
between time-varying clinical muscle weakness and early mortality across a 9-year observation 
period was determined using Kaplan-Meier methods and extended Cox regression. 
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Results: Out of the 8,326 individuals in the study, 1,799 deaths (21%) occurred during the 
observation period. Median follow-up time was 8.3 years (SD ±1.9 years). Weak individuals had 
a steeper decline in their survival trajectory, compared to non-weak individuals (Log-Rank test, 
p<.001). After adjusting for sociodemographic factors and time-varying smoking history, weak 
individuals were over 50% more likely to die earlier than non-weak individuals (HR=1.52, 95% 
CI= 1.15, 1.47).   
Conclusions: This is the first study to use muscle weakness cut-points derived in a nationally-
representative sample to identify those individuals who may be at greatest risk for premature 
mortality. Results underscore the importance of muscle weakness, as defined by handgrip 
strength, as a key risk factor for premature mortality in older Americans. 
 
4.2 Introduction 
Muscle weakness, as measured by handgrip strength, is associated with a host of negative 
health outcomes, including physical functioning limitations,1,2 disability,3–5 and 
multimorbidity.6,7 There is also a growing body of evidence linking muscle weakness with both 
cardiovascular8 and all cause-mortality.1,8–12 However, there are inconsistences in the magnitude 
of these effects. For example, the Foundations of National Institutes of Health (FNIH) 
Sarcopenia Project found a 74% and 48% greater mortality risk over 10 years for weak men and 
women, respectively, in a study comprised of 6 cohort studies.1 Similarly, the estimated risk of 
death was 36% among men and women with low grip strength in the Health ABC study over 4-
years of follow-up.11 In contrast, no relation between weak hand grip strength and mortality was 
 
 
 63 
found in a sample of older adults with chronic kidney disease13 while low grip strength was 
associated with a 49% increased risk of death in men, but not in women.14  
Part of the reason for these inconsistent findings may stem from the multiple ways in 
which muscle weakness has been measured and operationally defined. The Prospective Urban 
Rural Epidemiology (PURE) used study-specific grip strength tertiles8 whereas the Adult Health 
Study (AHS) compared men and women in the highest and lowest quintiles of hand grip strength 
among 5,000 individuals in Japan,15 and the FNIH Sarcopenia Project used grip strength 
thresholds calculated from a specific set of cohort studies and clinical trials.1 In the absence of 
consistent, population-derived cutpoints of clinical muscle weakness based on hand grip 
strength, the true consequences of muscle weakness for premature mortality remain unclear.  
In earlier work, sex/race-specific cutpoints for clinical muscle weakness were identified 
using data from a nationally-representative sample of older Americans in the U.S. Health and 
Retirement Study (Table 1).16 In subsequent analyses, these weakness cutpoints were shown to 
be predictive of incident physical disability over a 4-year period.4 What remains to be 
determined is the extent to which these cutpoints predict early mortality.  
---- Table 4.1 ---- 
The primary aim of this study was to examine the relationship between clinical muscle 
weakness, as defined by our previously published sex/race-specific grip strength cutpoints, and 
early mortality across a 9-year period from a nationally-representative sample of American 
adults aged 65 years and older. It was hypothesized that weak individuals would have a shorter 
survival compared to non-weak individuals, even after accounting for time-varying health and 
sociodemographic covariates.  
 
 
 64 
4.3 Methods 
Design and Sample Population 
Data came from the Health and Retirement Study (HRS), a nationally representative, 
multistage area probability survey of non-institutionalized, community dwelling Americans aged 
51 years and older. Study details have been previously described.17 Briefly, HRS is the longest 
running longitudinal study of older Americans in the United States, with consistent response 
rates of  ~85%.17 Sampled persons have been re-interviewed biannually since 1992, and new 
cohorts have been added to the original sample to maintain the nationally-representative nature 
of the survey over time.17 
In 2006, half the sample of HRS participants was randomly selected for an enhanced 
face-to-face interview that included physical measurements, and the other random one-half 
completed the same interview in 2008.18 Baseline collection of variables began in 2006 and was 
repeated every two years going forward. Proxy interviews and nursing home residents were 
ineligible to participate in the enhanced physical measurement protocol.  
We used 5 waves of longitudinal data from the 2006-2014 Health and Retirement Study. 
Analyses were restricted to Black and White community-dwelling adults aged 65 years and 
older. Individuals who reported to be “other” race were excluded from the analysis (n=487). 
Individuals who were missing on grip strength across all waves were excluded from the analysis 
(n=169), yielding a final sample of 8,326 individuals. 
Measures 
Hand grip strength 
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Hand grip strength, our primary exposure variable, was assessed using a Smedley spring-
type hand dynamometer (Scandidact, Denmark). Participants were instructed to squeeze the 
device as hard as they could and then let go. Grip strength assessments were administered while 
participants were standing with their arm at their side, and with the elbow flexed at a 90 degree 
angle.18 After one practice trial, measurements were taken with each hand, first with the 
dominant hand and then with the non-dominant hand. Two additional measurements were taken 
for both hands and the maximum measurement in kilograms (kg) from the four trials was used 
for the analysis. Among those missing on handgrip strength (n=169), the majority had a health 
problem (63%) or the interviewer did not feel it was safe for the respondent to participate (37%).  
Race/sex-specific cutpoints for clinical weakness were used to classify those who were 
weak versus not weak at each follow-up.16 The HRS hand grip strength cutpoints were 
previously found to have moderate to moderately high sensitivity in relation to slow walking 
speed for black and white men (range, SE: 69-75%, SP: 54.3-64.9%) and black and white 
women (range, SE: 60.5-90.5%, SP: 29.2-67.6%).16 Time-varying grip strength was used in the 
analyses.  
Mortality 
Mortality was ascertained through HRS linkages with the National Death Index or from 
contact with household members at each data collection wave through December 2014. Previous 
HRS tracking studies have indicated a 98.8% validation of deaths.17 Survival time was calculated 
based on an individual’s age in months from the start of their first interview until the end of 
observation period (December 31, 2014) or until death, which ever occurred first. Individuals 
who were alive at the end of the follow-up period or lost to follow-up were censored.  
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Covariates  
The following covariates were included: age (continuous), sex, self-reported 
race/ethnicity and education (5-level categorical variable, less than a high school degree, GED, 
high school degree, some college, and college and above). Smoking status, which was measured 
every 2-years, was included as a time-varying covariate and was categorized as current, former 
and never smoker based on self-report. Physical activity was assessed based on whether an 
individual reported taking part in sports or activities that were “moderately energetic” (i.e., 
gardening, cleaning the car, walking at a moderate pace). Individuals who reported hardly ever 
or never were classified as “inactive” while those who engaged in moderate activity more than 
once a week, once a week, one to three times a month were considered “active”. Body mass 
index (BMI) defined as weight in kilograms/(height in meters)2. Number of chronic health 
conditions was assessed based on the sum of eight self-reported medically diagnosed chronic 
health conditions (high blood pressure, diabetes, cancer, lung disease, heart disease, stroke, 
psychiatric problems and arthritis).  
Analytic Approach 
All statistical analyses were conducted using SAS software 9.4 (Cary, NC).19 Bivariate 
differences between individuals who were weak versus non-weak were assessed using t-tests for 
continuous variables and chi-squared tests for categorical variables. Descriptive analyses were 
weighted using HRS sampling weights and statistical significance was assessed with a two-tailed 
alpha of 0.05. The Kaplan-Meier method was used to generate time-to-event unadjusted baseline 
survival curves in which the median survival time was calculated. Log-rank tests were used to 
 
 
 67 
test whether the survival curves differed between weak versus non-weak individuals across the 
study period.  
Weighted, fully-adjusted, extended Cox models for time-dependent variables were used to 
estimate hazard ratios for mortality among weak versus non-weak individuals.20 Survival was 
defined as time from baseline interview to date of death, proxy-reported death, or last interview. 
Hazard ratios and 95% confidence intervals were obtained.  
4.4 Results 
Baseline demographic characteristics of the study sample are reported in Table 2. In this 
nationally-representative sample of 8,326 older adults (mean age= 79.9 years, SD=± 6.59 years), 
46% were considered weak at baseline based on the sex/race specific grip strength cutpoints. 
Weak individuals were more likely to be older compared to non-weak individuals (82 years of 
age vs. 78 years, respectively; p<.001), and women were more likely to be weak than men (65% 
vs. 35%, respectively; p<.001). Whites were more likely to be weak compared to Blacks (87% 
vs. 13%, respectively; p<.001).  
---- Table 4.2 ---- 
Across the 9-year study period, the median follow-up time was 8.3 (±1.9 SD) years. 
1,743 (21%) individuals died and 6,593 (79%) individuals were censored. Among those who 
censored, 6,570 were alive at the end of the study period and 23 were lost to follow up. Out of 
the 1,743 individuals who died, and 1,267 (72%) were weak at baseline and 532 (28%) were 
non-weak. When comparing the baseline survival curves of weak versus non-weak individuals 
across the 9-year observation period, the results of the Log-Rank test indicated they were 
significantly different from one another (p< .001) (Figure 4.1).  
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---- Figure 4.1 ---- 
---- Table 4.3 ---- 
Table 3 presents the results from the extended Cox models. In the unadjusted model 
(Model 1, Table 3), muscle weakness was associated with a nearly 60% greater risk of death over 
the follow-up period (Hazard Ratio (HR) =1.59, 95% confidence interval (CI)= 1.42, 1.77).  
After adjusting for sociodemographic factors and smoking history  (Model 2, Table 3) weak 
individuals were over 50% more likely to die earlier compared to non-weak individuals 
(HR=1.52, 95% CI= 1.15, 1.47) (Model 2, Table 3). Further adjusting for time-varying body 
mass, number of chronic health conditions, and physical activity resulted in an attenuation of 
hazard ratio, however the association remained significant (Model 3, Table 3). 
4.5 Discussion 
Using data from a nationally-representative sample of older Americans, this study 
demonstrated that muscle weakness, as indexed by validated thresholds of hand grip strength, 
was strongly associated with early mortality, even after accounting for other known risk factors. 
Across a 9-year follow-up period with time-varying measures of weakness, older adults 
classified as weak were 50% more likely to die earlier compared to those who were not weak, 
even after adjusting for other time-varying risk factors. These findings provide support that grip 
strength is an important clinical marker for identifying those who may be most at risk for 
negative health outcomes, including early mortality. 
The majority of studies focusing on the relationship between muscle weakness and 
mortality have relied on sample-specific definitions 3,7,10,21 and/or utilized data that are not 
representative of the diverse and rapidly growing population of older adults  in the United 
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States.2,22 For example, the FNIH Sarcopenia Project recently proposed cutpoints for clinical 
muscle weakness and mass but were unable to explore differences in defining muscle weakness 
by various subgroups due to small sample size.23 Similarly, the European Working Group on 
Sarcopenia in Older People (EWGSOP) proposed muscle weakness cutpoints that relied on a 
sample-specific definition derived in cross-sectional setting.24  As a result, there is a paucity of 
research that has adequately quantified the true burden of muscle weakness on survival in older 
Americans within a longitudinal, racially/ethnically diverse context.  
The results of this study are consistent with a growing body of research that has 
demonstrated that muscle weakness, as measured by hand grip strength, is associated with 
mortality.8,12,25 Indeed, several epidemiological studies have found grip strength to be inversely 
related to all-cause and cause-specific mortality in mid-life9,26, older1,6,10 and the oldest old27 
populations, although in a few studies, this relationship held for men but not women.6,28 In a 
meta-analysis comprised of 14 studies and close to 54,000 participants, those in the lowest 
quartile of grip strength measurement were 67% more likely to die earlier compared to those in 
the highest quartile, even after adjusting for sex, body mass and age.29 In the PURE study among 
nearly 140,000 adults 35-70 years of age with 4 years of follow-up, poor grip strength was the 
strongest predictor of early cardiovascular and all-cause mortality, even compared to other 
traditional clinical indicators such as systolic blood pressure.8 Thus, muscle strength remains an 
important and robust predictor of mortality risk as individuals age over time. 
Despite previous cross-sectional work that has almost exclusively focused on muscle 
mass, a growing body of longitudinal research has demonstrated that declines in muscle strength 
outpaces that of muscle mass,11,30,31 implying that muscle strength may not only be an important 
predictor of muscle health but a more sensitive measurement with respect to clinical intervention. 
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Moreover, hand grip strength, which is the most common assessment of muscle strength in 
research and clinical practice,32 has been found to be independently associated with mobility 
limitations, physical functioning and disability.4,33 Therefore, there is a growing call among 
researchers and clinicians to consider muscle strength as a composite biomarker of muscle mass 
and function.34  
While the mechanisms underlying the muscle weakness-mortality association have not 
been fully elucidated, there are likely several underlying pathways driving the association 
between muscle weakness and premature mortality. Several studies have shown muscle 
weakness is associated with higher fasting insulin levels35 and a precursor to insulin resistance.36 
Muscle weakness has also been found to be independently associated with an increased odds of 
experiencing diabetes37 and metabolic syndrome38 in adults. Maintaining muscle strength may 
play a critical role in preventing metabolic and cardiovascular disease risk with aging, and thus 
protecting against premature mortality. 
Weak individuals are also more likely to report greater difficulty in completing basic self-
care activities25 and experience greater odds of disability onset, progression and persistence over 
time.4 Therefore, the association between muscle weakness and mortality may be mediated by 
changes in physical functioning. Individuals with low levels of physical activity are more likely 
to experience declines in muscle strength, thereby entering a negative feedback loop where weak 
individuals are unable to participate in physical activity and are more vulnerable to declines in 
their physical health status, leading to subsequent declines and risk for early mortality. Taken 
together, handgrip strength may function as a “a crude but effective will to live meter”39 even if 
the underlying mechanisms of the strength-mortality association may not be fully understood.  
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Of note, we found that the estimated survival functions for weak and non-weak 
individuals at baseline did not begin to diverge until month 50, a little more than 4-years into the 
follow-up period. We interpret this observation to mean that muscle weakness is associated with 
a slow decline in health and functioning that may be indirectly associated with the onset of 
premature mortality. In other words, muscle weakness does not lead to an immediate, precipitous 
decline in health, but rather may initiate a cascade of negative health events associated with 
compromised survival in later life. Indeed, understanding the complex, underlying pathways 
driving the results observed in this study warrants further investigation. 
The results of this study support the use of nationally representative grip strength 
cutpoints for clinical muscle weakness derived in a diverse sample of older adults16 as a brief 
screening tool to easily identify those who may be most vulnerable to negative health outcomes. 
Given the ease and cost-effectiveness of measuring hand grip strength, combined with the robust 
literature demonstrating that grip strength may serve as a biomarker of healthy aging, the 
cutpoints utilized in this study can be applied in other data that seek to define muscle weakness. 
These cutpoints can also be used in the clinical setting as a quick and inexpensive way of 
identifying those older adults who may be most vulnerable to future declines in health status.  
 This study had several notable strengths. First, to the best of our knowledge, this is the 
first study using sex/race-specific muscle weakness cutpoints derived in a nationally-
representative, diverse sample of older Americans to examine the relationship between clinical, 
time-varying muscle weakness and mortality. Therefore, the results presented in this manuscript 
can be generalized to community-dwelling, older Black and White American adults aged 65 
years and older in the United States. Second, the statistical analysis used both time-varying 
weakness variables and time-varying covariates, an important analytic consideration when 
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examining a longitudinal association when exposure status is known to change over time. 
Previous research examining the muscle weakness-mortality association included fixed, baseline 
covariates only. This approach makes the assumption that muscle weakness remains stable over 
time, which is unlikely to be the case.12 Third, the cutpoints utilized in this study to define 
muscle weakness were derived using handgrip strength measurements. Grip strength 
dynamometers have been shown to be a cost effective, quick and a simple instrument that can be 
readily utilized within the clinical setting.40 Therefore, the grip strength cutpoints presented in 
this paper offer clinicians the opportunity to incorporate handgrip assessments into medical 
practice for screening and identifying at risk older individuals.  
Despite these strengths, this study has several limitations. First, participants were 
interviewed every 2 years and there may be other competing events (i.e., acute hospitalization 
following a medical event) in the intervening period that could not be accounted for. Future 
studies should examine the muscle weakness-mortality association in surveys that have more 
frequent follow-up over time. Second, the results of this study can only be generalized to 
individuals aged 65 years and older. Since the cutpoints utilized in this study were derived in an 
older population, we are unable to assess the muscle weakness-mortality association in middle 
age, which may serve as an important age for intervention.  
This is the first study to use muscle weakness cut-points derived in a nationally-
representative sample of Black and White older Americans to identify those who may be at 
greatest risk for premature mortality. Results underscore the importance of muscle weakness as a 
key risk factor for premature mortality in older Americans. 
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4.6 Tables and Figures 
Table 4. 1 Cutpoints for clinical muscle weakness by race/sex in the Health and Retirement 
Study. 
2006/2008 HRS Total Sample (N= 8,725) 
 
White Males Black Males  White Women  Black Women 
 
(n=3,279) (n=422)  (n=4,286)  (n=738) 
 
Cutpoint (kg) Cutpoint (kg)  Cutpoint (kg)  Cutpoint (kg) 
Weak  <35 <40 
 
<22 
 
<31 
Normal ≥35 ≥40   ≥22   ≥31 
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Table 4. 2 Baseline demographic characteristics of adults age 65+ in the Health and Retirement 
Study (n=8,326), 2006-2014. 
 
Weak 
Non-
Weak p-value 
 Mean (SD) Mean (SD)  
Age (y) 78.4 (6.9) 82.6 (5.6) <.0001 
BMI 25.9 (5.2) 27.3 (5.8) <.0001 
Chronic Conditions  3.1 2.7 0.2 
 
Na (%)b Na (%)b  
Sex   
<.0001 
Males 1339 (35) 
2235 
(49.6) 
 
Females 2482 (65) 
2270 
(50.4)  
Race/Ethnicity   <.0001 
Whites 3011 (86.9) 
4254 
(56.9)  
Blacks 810 (78.1) 251 (21.9)  
Education 
   Less than a HS degree 1102 (56.5) 834 (43.5) <.0001 
GED 146 (39.6) 221 ( 60.4)  
High School  1270 (46) 1543 (54)  
Some College 692 (41.9) 955 (58.1)  
College and above 611 (38.8) 951 (61.2)  
Smoking Status 
  
<.0001 
Never 1757 (48.5) 
1873 
(51.5)  
Former  1816 (44.2) 
2284 (55.8 
)  
Current 248 (40.6) 348 (59.4)  
Physical Activity   <.0001 
Active 1951 (37) 3176 (63)  
Inactive 1870 (59.4) 
1329 
(40.6)  
aNumber of participants, unweighted 
   b Percentage, weighted 
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Figure 4. 1 Kaplan Meir Baseline Survival Curves: Comparing Weak vs. Non-Weak Individuals 
(N=8,326), 2006-2014. 
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Table 4. 3 Extended Cox Proportional Hazard Models: Association between Muscle Weakness and Mortality in the Health and 
Retirement Study (N=8,326), 2006-2014. 
  Model 1 Model 2 Model 3Ϯ 
 Hazard Ratio 95% CI Hazard Ratio 95% CI Hazard Ratio 95% CI 
Weaka 1.59*** 1.42, 1.77 1.52*** 1.15, 1.47 1.77*** 1.43, 2.21 
Demographic Factors       Age (years)   1.02** 1.01, 1.03 1.04*** 1.02, 1.05 
Femaleb   0.73*** .66, .81  0.69 .57, .87 
Blackc   0.86 .74, 1.01 0.76 .58,.99 
Educationd       
GED   0.78* .60, 1.00 1.18 .77, 1.78 High School   0.71*** .63, .82 0.76 .60, .96 Some college   0.71*** .63, .83 0.89 .68, 1.16 College and above   0.54*** .46, .64 0.85 .63, 1.14 
Smoking Statuse       
Former   1.42*** 1.27, 1.59   
Current   2.06*** 1.70, 2.49             
  * p<.05       **p<.01       ***p<.0001       a Reference group is Non-weak 
     b  Reference group is Male       c  Reference group is 
White  
     d Reference group is Less than High School education 
    e Reference group is Never Smoker 
     Ϯ Further adjusted for body mass index, chronic conditions and physical activity  
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CHAPTER 5.  Life Course Determinants Of Muscle Weakness: The Role Of Stress And 
Trauma 
5.1 Abstract 
Background: Muscle weakness, as measured by handgrip strength, is associated with disability, 
physical functioning and mortality; however, the extent to which grip strength trajectories among 
older adults are shaped by social adversity experienced earlier in the life course is unknown.  
Methods: Using data from the Health and Retirement Study (N= 20,472, Mean Age= 63.8 
years), we employed gender-stratified growth curve models to investigate whether traumatic and 
stressful events experienced both across the life course and at distinct life stages were associated 
with trajectories of grip strength in a nationally representative sample of older adults.  
Results: We found that life course trauma and stress experienced during emerging/early 
adulthood (18-42 years) was associated with both mean grip strength at age 50 and trajectories of 
grip strength over time. Among Black men, stress and trauma experienced during emerging/early 
adulthood was not only related to higher mean grip strength at age 50, but also associated with 
steeper declines as individuals aged over time compare to White men. Among Black women, 
traumatic events during emerging/early adulthood were associated with lower mean grip strength 
at age 50. 
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Discussion: Results shed light on the importance of considering how one’s social environment 
shapes grip strength trajectories among older adults and may also contribute to racial/ethnic 
disparities in muscle weakness in later life, particularly among Black Men and Women.  
 
5.2 Introduction 
Muscle weakness, as measured by handgrip strength, is associated with a host of negative 
health outcomes, including physical functioning limitations, 24,47 disability,14,15,41,70 
multimorbidity,17,76,175 and both cardiovascular17,26 and all cause-mortality.12,26,47,73,74,78,176 In the 
United States, it is estimated that 55% of older men and 45% of older women have muscle 
weakness.179 Racial disparities in muscle weakness have also been uncovered by recent research 
showing that 55% of Black Males and 88% of Black women meet criteria for clinical muscle 
weakness compare to 37 % of White men and 48% of White women.179 The implications of 
compromised muscle strength in later age may be especially consequential since older Black 
adults also have a higher prevalence of mobility limitations compared to Whites.183 Thus, a “dual 
burden” of muscle weakness combined with greater mobility limitations may exacerbate physical 
health disparities in later age and lead to greater challenges associated with the recovery process.  
While physical activity184, gender 13, chronic disease status185 and nutrition75 in older age 
have been identified as important determinants of muscle weakness, significant unexplained 
variability remains in identifying which individuals become weak in older age. One of the 
primary reasons for this may be that research has largely focused on proximal determinants of 
muscle weakness among older adults and less on early and midlife risk factors. It is possible that 
a better grasp of the risk factors earlier in the life course would not only help identify those who 
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are both most at risk for muscle weakness in older age but also who would benefit most from 
early intervention.  
An enhanced understanding of the upstream social factors that drive differential 
vulnerability to muscle weakness in later life is of critical public health importance. There is a 
well-established body of evidence documenting how social stress and trauma “gets under the 
skin” to impact physical health in older age. 114,116,186 However, to date, few studies have 
investigated the role social stress and trauma plays in the development of muscle weakness in 
later age, and whether previously observed disparities in muscle weakness may be exacerbated 
due to differential exposure to social stress and trauma. Therefore, this study addresses a major 
gap in the literature by explicitly testing in a longitudinal setting whether exposure to stress and 
traumatic events experienced across the life course influence trajectories of muscle weakness in 
older age within a nationally-representative, diverse group of Americans. This chapter will begin 
by first reviewing several related bodies of literature integral to our understanding of the 
relationship between life course risk factors and muscle weakness in a middle and older aged 
adults.  I first review life course epidemiology, followed by stress and trauma as independent risk 
factors for physical and mental health, and conclude with a brief review of how these factors 
may shape racial/ethnic disparities in health. 
Life Course Epidemiology: Theoretical underpinnings and conceptual models 
Life course epidemiology has been used to elucidate how seemingly unrelated physical 
and social exposures experienced during gestation, childhood, adolescence, young adulthood and 
middle age drive disease outcomes in later life.86 From a life course perspective, aging is seen 
from a developmental lens in which distinct phases of adulthood are marked by specific life 
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events and role transitions where certain stressors/protective factors may be more or less likely to 
occur.86,87 For example, childhood is often defined by gains in education while adolescence is an 
important window of development when young people begin to assert their independence, make 
life style choices and establishes health behaviors that will often persist into adulthood.88 The 
emerging/early period of adulthood (typically occurring in the 20’s to late 30’s and early 40’s) is  
typically characterized by the establishment of one’s career, marriage, parenthood and asset 
acquisition that has a lasting effects on health and SES in later life.89–91 Lastly, the midlife period 
(mid 40s to early 60s) is often typified by changes in health status as a result of early life health 
behaviors and life chances.  
While the life course framework is useful in helping to identify the timing and potential 
impact of when and how events unfold, it is important to note that historically, life course theory 
has made assumptions about an “institutional pattern” regarding how individuals transition 
through different life stages.  Thus, as Kohli suggests, thinking of the life course as a unified, 
institutional model has become increasingly inappropriate as the life course has become more 
differentiated and heterogeneous over time, particularly with respect to gender and 
race/ethnicity.187 Since a life course framework often examines how individuals move in and out 
of various social systems (i.e., educational system, criminal justice system, labor markets, etc.), 
disparities arise when the amount of time spent is shorter for some groups than for others. 188 For 
example, Oppenheimer et al. found that among those with a high school degree, ~20% of Black 
men married within 4 years of graduation, compared with 40% of White men.189  
Despite the variation in the life course with respect to race, gender and economic 
resources, two general conceptual models within life course theory have been proposed to 
understand how early life antecedent events drive health outcomes in older age: the critical 
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period model and the accumulation of risk model.86 The critical period model suggests that there 
are important life stages in which an individual experiences adverse events and exposures that 
may have crucial consequences on their health in later life. This conceptual model is largely 
rooted in the fetal origins hypothesis, which linked poor maternal nutrition in utero to increased 
risk of coronary heart disease and diabetes in later life.92 One well documented example is 
literature showing that childhood SES is directly associated with cardiovascular disease,93 
stroke,94,95 physical functioning96,97 and lower levels of grip strength98 in older adults. Similarly, 
experiencing physical, sexual and emotional abuse during childhood is associated with increased 
risk of adverse physical and mental health outcomes in later life. 99,100  
The accumulation of risk model posits that negative exposures gradually accumulate 
across the life course, ultimately influencing health status in later life.101 This model has been 
used to explain why socioeconomic differentials in health exist across a wide range of diseases.86 
For example, early childhood conditions may set individuals on risk trajectories of cumulative 
advantage/disadvantage with those from lower SES backgrounds experiencing a faster decline in 
health compared to those from higher SES backgrounds, ultimately leading to widening health 
disparities in later life.102,103 The accumulation of risk model has been applied to examine 
physical health outcomes. For example, physical inactivity, smoking, heavy drinking, social 
isolation, fair/poor perceived health and prevalence of chronic symptoms and conditions across a 
30-year period of emerging and midlife adulthood was associated with increased risk of frailty in 
a community dwelling sample of older adults.104  
 
Life Course Epidemiology & Muscle Weakness 
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There is growing interest in the role early and midlife factors play in the preservation of 
muscle strength in later life. However, the majority of research has almost exclusively focused 
on early life anthropometric indicators showing higher birth weight to be associated with greater 
muscle strength adulthood.105 In the Hertfordshire Ageing Study, lower birth weight and weight 
in the first year of life were significantly associated with lower grip strength 60-70 years later. 
This relationship, while somewhat attenuated, remained significant after adjusting for body size, 
indicating that one’s early environment may be of critical underlying importance.106 Pre-pubertal 
growth has also been found to be associated with midlife grip strength.107 
More recently, several studies have demonstrated that socioeconomic conditions 
experienced across the life course may also be linked to muscle health in later life. A recent 
systematic review found modest, positive associations between childhood SES and later life grip 
strength, even after adjusting for adult SES and current body size.97 Wealth in later life was 
found to be inversely associated with grip strength in a sample of older Europeans, while 
education, income and occupation were not, suggesting that earnings accrued across the life 
course may be important in maintaining grip strength in later life.108 Results from a British birth 
cohort study indicated that higher levels of material deprivation (i.e., not having a car, not 
owning one’s home) were inversely related to grip strength in later life.98 Low income and low 
education were found to be significantly associated with decreased grip strength among an 
elderly sample of Korean men.109 More recently, childhood misfortune was found to be related to 
lower handgrip strength in men, but not in women. 110   
 
Stress, Trauma and the Life Course 
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A substantial body of literature has demonstrated that one’s social context is 
consequential for health. Previous studies have found social and economic hardships   
experienced both in childhood111 and throughout the life course are associated with mental and 
physical health outcomes in later life.112,113 There is evidence to suggest that exposure to stress 
and trauma throughout one’s life may be linked to poorer health outcomes in later life.  
Previous research investigating the downstream cascade that emerges after experiencing 
stress and trauma early in the life course suggests there are several important mediators on the 
causal pathway between stress, trauma and muscle weakness in later life. Indeed, experiencing 
stressful and traumatic events earlier in life may lead to maladaptive coping190, which in turn 
may lead to higher levels of BMI since previous research has shown that victims of trauma may 
use food to “anaesthetize” themselves from unpleasant feelings and memories.191 Research also 
shows that individuals who experience greater levels of stress and trauma are more likely to 
smoke.192 As a result, individuals who experience higher levels of stress and trauma may be less 
likely to engage in physical activity which may lead to a higher prevalence of chronic 
conditions.193  
Social stress has been found to be associated with mental health status and depression 
among older adults.114,115 Traumatic events have been shown to have a strong relationship on 
both immediate and long-term health outcomes. Trauma in particular may be especially 
consequential for health. Pearlin (2005) noted that trauma may be the most potent form of stress, 
characterized by the “magnitude of their onerousness…and by their sudden and violent 
character” (pg. 210) that have negative consequences for health in later life.116 Despite the 
known links between stress and trauma with later life physical health, no studies have directly 
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examined whether stress and trauma experienced throughout the life course, and specifically 
among distinct critical life periods, is associated with muscle health in later life.  
 
Racial/ethnic health disparities  
Racial/ethnic disparities in health are pervasive and persistent in the United States.117,147 
Non-Hispanic Black Americans have a higher prevalence of several chronic conditions118, live 
more years with chronic health problems119 and have higher rates of disability120,121 compared to 
Non-Hispanic White Americans. Similarly, among sub-groups of Hispanics, Hispanic Americans 
have been found to have higher rates of chronic disease and have worse functional health.122,123 
However, mortality rates, particularly among Mexican Americans, appear to be comparable and 
in some cases exceed all-cause mortality for Non-Hispanic Whites.124 Racial/ethnic disparities in 
physical functioning, mobility and disability are also well documented.119,121,125,126 
In seeking to understand why these disparities persist, many studies have examined 
socioeconomic status (SES) as a key explanatory contributor. Indeed, several studies have shown 
that after accounting for SES, disparities in functional health between Blacks and Whites become 
partially attenuated, and in some cases, disappear121,127. However, the evidence regarding the 
association between SES and functional health remains equivocal. Other studies investigating 
this relationship have found that even after accounting for SES differences, disparities in 
disability and physical functioning persist, 128 suggesting that other explanatory factors may be at 
play. 
 
Social adversity and racial/ethnic disparities in health 
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While several studies have shown racial/ethnic minorities to have a higher prevalence of 
lifetime stress and trauma194, this evidence is largely mixed. Nonetheless, individuals in more 
advantaged social positions have better access to resources and opportunities in early life, which 
can offset or reduce exposure to negative life events, while those in more disadvantaged social 
positions are at greater risk of negative life events on account of reduced access and 
opportunity195. Moreover, since the root of disadvantage is structural and often experienced in all 
aspects of one’s life, persistent advantage or disadvantage can become compounded over time, 
ultimately leading to a widening in racial/ethnic health disparities across populations.196 As a 
result, it can be hypothesized that disparities in muscle strength between Whites, Blacks and 
Hispanics may be indirectly related to differential exposure to stress and trauma across the life 
course, a view that is consistent with the accumulation of risk theory.  
Based on the above, the primary objectives of this study are twofold: (1) To identify 
whether life course stress and trauma are associated with grip strength trajectories in a nationally 
representative sample older Americans followed across an 8-year period, and; (2) To examine 
whether the timing of when these stressful and traumatic events across the life course and at 
distinct life stages is associated with changes in grip strength in racially and ethnically diverse, 
longitudinal study of Americans aged 50 years and older.  
5.3 Methods 
 
Study Design and Sample Population 
Data came from the Health and Retirement Study (HRS), a nationally representative, 
multistage area probability survey of non-institutionalized, community dwelling Americans aged 
51 years and older. Study details have been previously described.136 Briefly, HRS is the longest 
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running longitudinal study of older Americans in the United States, with consistent response 
rates of  ~85%.136 Sampled persons have been re-interviewed biannually since 1992, and new 
cohorts have been added to the original sample to maintain the nationally-representative nature 
of the survey over time.136  
In 2006, half the sample of HRS participants was randomly selected for an enhanced 
face-to-face interview that included physical measurements, and the other random one-half 
completed the same interview in 2008.137 Additionally, in the same 2006 survey wave, HRS 
began collecting data on psychological and social well-being that was left behind after the 
enhanced face-to-face interview.197 Participants completed these questions and then mailed in 
their responses. For this analysis we used 5 waves of longitudinal data from the 2006-2014 
Health and Retirement Study.  
Our initial population included 26,163 individuals who were 50+ years old and 
community-dwelling. Individuals who had died (n=1,429), reported “other” for their 
race/ethnicity (n=745), or were missing on grip strength across all waves (n=3,517) were 
excluded, yielding a final analytic sample of 20,472 Black, White, Hispanic men and women 
who were 50 years and older at the time they received their first grip strength measurement 
(baseline).  
Measures 
Hand grip strength 
Hand grip strength, our primary outcome of interest, was assessed using a Smedley 
spring-type hand dynamometer (Scandidact, Denmark). Participants were instructed to squeeze 
the device with the dominant hand as hard as they could and then let go. Grip strength 
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assessments were administered while participants were standing with their arm at their side, and 
with the elbow flexed at a 90 degree angle.137 After one practice trial, two measurements were 
taken with each hand, alternating hands. The maximum measurement in kilograms (kg) from the 
four trials was used for the analysis.   
Life Course Cumulative Trauma and Stress 
As part of the leave behind self-administered questionnaire, participants were asked to 
answer a series of questions pertaining to traumatic and stressful life events experienced across 
the life course (yes/no). Example of trauma indicators included: “Has a child of yours ever 
died?”, “Did you ever have a life-threatening illness or accident?”, and; “Have you ever been in a 
major fire, flood, earthquake, or other natural disaster?”  Life course cumulative trauma was 
defined as the sum of all traumatic events at any wave based on whether a respondent answered 
“yes” to a series of 11 questions (Range: 0-11). The full list of questions pertaining to traumatic 
life events are presented in supplementary table 5.3. 
Participants were also asked about stressful life events. These indicators inquired about 
stressful life events (yes/no) experienced across the life course. Examples of stressful life events 
questions included: “At any time in your life, have you ever been unfairly denied a bank loan”, 
“Before you were 18 years old, did you ever have to do a year of school over again?”, and, 
“Have you involuntarily lost a job for reasons other than retirement at any point in the past five 
years?”. Life course cumulative stress was defined as the sum of all stressful life events reported 
in the series of 11 questions (Range: 0-11). The full list of questions pertaining to stressful life 
events are presented in supplementary table 5.4. 
Life Stage Trauma and Stress 
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If a respondent answered “yes” to any of the traumatic and/or stressful life event 
indictors, they were then asked to record the year it occurred. In order to calculate the age at 
which the respondent experienced the stressful or traumatic event we subtracted the respondent’s 
birth year from the year they experienced the event. Summary stress and trauma variables were 
then created for three critical life stages: Early Childhood (age 0-17 years), Emerging/early 
adulthood (age 18-42 years) and Midlife (age 43-67 years).  Since the stressful life event 
questions largely focused on events pertaining to job and financial security, there were no 
stressful life events recorded in the childhood period.  This resulted in five key exposure 
variables (2 stressful life event summaries in emerging/early adulthood and midlife, and 3 trauma 
event summaries in childhood, emerging/early adulthood and midlife) that capture the total 
number of stressful and traumatic events experienced during these distinct life stages.  
Stress and trauma variables were missing for 3,182 individuals in the leave behind survey 
and were excluded from analyses with any of the exposure variables. These individuals were not 
significantly different from those who did complete the questions with respect to age, number of 
chronic conditions or BMI. However, individuals who were missing on the stress/trauma 
questions were more likely to report more difficulty with activities of daily living (ADL) than 
those who answered the stress/trauma questions (mean number of ADL limitations = .42 vs. .29, 
respectively). 
Sociodemographic variables 
The following time invariant covariates were included in the analysis: (1) Age was 
defined continuously in number of years; (2) Race/Ethnicity was self-reported and 3 dummy 
indicators were created for Non-Hispanic Black, Non-Hispanic White (referent) and Hispanic 
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individuals; (3) Gender was treated as dummy variable coded 1 for females and 0 for males; (4) 
Education was modeled as a binary dummy variable contrasting those with greater than or equal 
to 12 years of education compared to those with less than 12 years of education. Since 
educational attainment is a known risk factor for stress and trauma198 and is also related to 
muscle weakness,199 it was included as a confounder variable and was adjusted for in the 
statistical models. 
The following time-varying covariates were included as hypothesized mediators in the 
causal pathway between earlier life stress/trauma and muscle strength in later age: (1) Smoking, 
categorized as current, former and never (referent) smoker based on self-report; (2) Physical 
activity was assessed based on whether an individual reported taking part in sports or activities 
that were “moderately energetic” (i.e., gardening, cleaning the car, walking at a moderate pace). 
Individuals who reported hardly ever or never were classified as “inactive” while those who 
engaged in moderate activity more than once a week, once a week, one to three times a month 
were considered “active”; (3) Body mass index (BMI) defined as weight in kilograms/(height in 
meters)2; (4) Number of chronic health conditions was assessed based on the sum of eight self-
reported medically diagnosed chronic health conditions (high blood pressure, diabetes, cancer, 
lung disease, heart disease, stroke, psychiatric problems and arthritis).  
Analytic Approach 
Growth curve models were used to examine trajectories of grip strength over mid to late-
adulthood. Due to the established gender differences in grip strength, separate models were 
estimated for men and women. Growth curve models are a type of mixed model that account for 
correlations and clustering between and within individuals over time.200 A two-level model was 
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specified using 5 waves of HRS data across an 8 year time period (2006-2014). Age in years was 
used as the primary time indicator from age 50 to 99, which was centered at age 50 to aid in 
parameter interpretation (setting age 50 to 0). The functional form of age was tested as linear, 
quadratic and cubic terms in order to capture potential non-linearity in trajectories of grip 
strength with aging. However, only the linear and quadratic terms were significant, and were 
retained in all models.  
The structure of this model can be expressed by equations at each level. At level 1 
(within-person model), maximum grip strength scores are nested with individuals (i) as defined 
by the following statement: 
GSti = 𝜋𝜋0𝑖𝑖 +  𝜋𝜋1𝑖𝑖(𝑎𝑎𝑎𝑎𝑎𝑎 − 50)𝑡𝑡𝑖𝑖 +  𝜋𝜋2𝑖𝑖 (𝑎𝑎𝑎𝑎𝑎𝑎 − 50)2 + 𝑟𝑟𝑡𝑡𝑖𝑖   (1) 
where 𝜋𝜋0𝑖𝑖 is the expected maximum grip strength score for person i at age 50 (centered age), 𝜋𝜋1𝑖𝑖 
captures the linear rate of change in grip strength with age, 𝜋𝜋2𝑖𝑖 captures the quadratic rate of 
change in grip strength, and 𝑟𝑟𝑡𝑡𝑖𝑖 captures the within-person residual (the part of an individual’s 
grip strength at time t that cannot be explained by time/age) and is assumed to have a normally 
distributed mean of 0 and variance of 𝜎𝜎2. 
The level-1 parameters are then modeled as a function of the individual characteristics at 
level-two. The level-2 between person sub-model assumes that grip strength intercepts and 
slopes vary across individuals, and we explicitly model these difference based on the following 
equations using race/ethnicity as a working example: 
𝜋𝜋0𝑖𝑖 =  𝛽𝛽00 + 𝛽𝛽01(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏) + 𝛽𝛽02(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏) + 𝑎𝑎0𝑖𝑖    (2.1) 
𝜋𝜋1𝑖𝑖 =  𝛽𝛽10 +  𝛽𝛽11(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏) +  𝛽𝛽12(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏)    (2.2) 
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𝜋𝜋2𝑖𝑖 =  𝛽𝛽20 + 𝛽𝛽21(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏) + 𝛽𝛽22(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏)    (2.3) 
In the equations above, the intercept and age slopes from equation 1 are modeled as a 
function of race/ethnicity, where 𝛽𝛽01 represents the difference in grip strength (intercept) for 
Blacks compared to Whites at age 50, 𝛽𝛽11 represents the difference in the rate of change (linear 
slope) of grip strength for Blacks compared to Whites and 𝛽𝛽21 represents the difference in the 
rate of change (quadratic slope) of grip strength for Blacks compared to Whites. Similarly, 
𝛽𝛽20 represents the difference in grip strength (intercept) for Hispanics compared to Whites at age 
50, 𝛽𝛽12 represents the difference in the rate of change (linear slope) of grip strength for Hispanics 
compared to Whites and 𝛽𝛽22 represents the difference in the rate of change (quadratic slope) of 
grip strength for Hispanics compared to Whites. The residual error (𝑎𝑎0𝑖𝑖) captures the random 
error in the intercept across individuals. Random variance around the slope coefficients were not 
estimated due to problems with model convergence. Substituting equations 2.1 - 2.3 into 
equation (1) yields the full composite model: 
𝐺𝐺𝑟𝑟𝑖𝑖𝑖𝑖 𝑆𝑆𝑆𝑆𝑟𝑟𝑎𝑎𝑖𝑖𝑎𝑎𝑆𝑆ℎ𝑡𝑡𝑖𝑖=  𝛽𝛽00 +  𝛽𝛽01(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏) +  𝛽𝛽02(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏) +    𝛽𝛽11(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏)(𝑎𝑎𝑎𝑎𝑎𝑎 − 50)+  𝛽𝛽12(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏)(𝑎𝑎𝑎𝑎𝑎𝑎 − 50) +     𝛽𝛽21(𝑏𝑏𝑏𝑏𝑎𝑎𝑏𝑏𝑏𝑏)(𝑎𝑎𝑎𝑎𝑎𝑎 − 50)2  +  𝛽𝛽22(ℎ𝑖𝑖𝑖𝑖𝑖𝑖𝑎𝑎𝑖𝑖𝑖𝑖𝑏𝑏)(𝑎𝑎𝑎𝑎𝑎𝑎 − 50)2 +   𝑎𝑎0𝑖𝑖 + 𝑟𝑟𝑡𝑡𝑖𝑖 
We used the MIXED procedure in SAS 9.4 to estimate the linear mixed models using full 
information maximum likelihood. The distribution of the residuals showed a good approximation 
to normality with little deviation from the diagonal in the normal probability plots, justifying the 
linear model. Nested models were compared using the following goodness-of-fit indices: (1) 
Change in the -2log likelihood, which follows a 𝜒𝜒2distribution where the degrees of freedom as 
the same between nested models, (2) Bayesian Information Criterion (BIC), where models with a 
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lower BIC indicate better model fit, and; (3) Proportion of variance in grip strength that is 
explained by a model (pseudo 𝑅𝑅2), which is calculated by squaring the correlation between the 
observed and predicted grip strength values. We also tested for mediation by adding each 
hypothesized mediator individually to assess change in the estimate of our primary exposure.  
5.4    Results 
We first present descriptive statistics by gender and race/ethnicity in separate tables for 
men (Table 5.1A) and women (Table 5.1B) and proceed in discussing the model results for men 
(Table 5.2A) and women (Table 5.2B) separately below.  
Results for Men 
Descriptive Statistics 
Among the 8,847 men included in this analysis, 17% were Black, 70% were White and 
13% were Hispanic (Table 5.1A). White men were slightly older (63.5 years) compared to Black 
(61.1 years) and Hispanic (61.1 years) men.  White men had the highest mean grip strength at 
43.6 kg while Hispanic men had the lowest at 39.8 kg. Black men had a mean grip strength of 
42.1 kg. The average number of chronic conditions was relatively similar across all three 
race/ethnic groups (range= 1.7-1.9 conditions). The average body mass index was also 
comparable across Black, White and Hispanic men (mean BMI range= 28.5-29.2 kg/m2). While 
physical activity and smoking levels were similar across all groups, there were notable 
differences in educational attainment. Fifty-nine percent of White men had 12 or more years of 
education compared to 42% of Black men and only 28% of Hispanic men.  
When examining the distribution of trauma across the life course, roughly one in 4 men 
reported no traumatic event from birth through age 67 (Table 5.1A). On average, Black men 
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experienced slightly higher levels of trauma (mean= 1.9 events) compared to Whites (1.7 events) 
and Hispanics (1.8 events).  The distribution of the number of traumatic events by race/ethnicity 
was relatively similar, although Black and Hispanic men were somewhat more likely to report 3 
or more traumatic events over the life course compared to White men. However, there were 
notable race/ethnic differences as to when these events occurred in the life course. In early 
childhood (0-17 years old), half of Black men and 46% of White men reported experiencing 1 or 
more traumatic events compared to 37% percent of Hispanic men. The number of traumatic 
events experienced during emerging/early adulthood (18-42 years) and midlife (43-67 years) 
were relatively comparable across race/ethnic groups. 
There were also noticeable race/ethnic differences in the number of stressful life events 
experienced over the life course. Black men experienced more stressful life events (mean= 1.7 
events) across the life course compared to Whites (1.2) and Hispanics (1.3). Thirty-two percent 
of Black men reported 3 or more stressful life events compared to 19% of White men and 22% of 
Hispanic men. The life stage breakdown as to when these events occurred also varied by 
race/ethnicity. Black men were more likely to report one or more stressful life event in 
emerging/early adulthood (30%) compared to White (20%) and Hispanic (17%) men. This was 
also the case for stressful life events experienced during midlife with 40% of Black men 
reporting one or more event compared to 32% of White men and 36% of Hispanic men. 
---- Table 5.1A ---- 
Growth Curve Models 
Unconditional Growth Model 
 
 
 94 
Results for the growth curve model for men are presented in Table 5.2A. In the 
unconditional growth model (Model A), the mean grip strength for men at age 50 is 48.6 kg and 
there is a significant negative linear and quadratic time effect indicating that grip strength 
declines with age. For each additional year of age, men lose, on average, .31 kg per year (p< 
.0001) and this decline accelerates with age (significant quadratic term of -.007 kg per year2).  
---- Table 5.2A about here ----  
Race/Ethnicity 
When adding  race/ethnicity to the model (Model B Table 5.2A), White men at age 50 
have a mean grip strength of 50.3 kg (the intercept, p< .0001) while both Black and Hispanic 
men have statistically significant lower average grip strengths of 46.7 kg (β= -3.6, p<  .0001) and 
45.4 kg (β= -4.9, p<.0001), respectively, at age 50. However, there were no significant 
differences in the rate of decline in grip strength with age by race/ethnicity (coefficients for rate 
of change by race/ethnicity, Model B). Predicted grip strength trajectories based on this model 
are plotted in Figure 5.1.  
---- Figure 5.1 about here ---- 
Life Course and Life Stage Trauma 
Model C (Table 5.2A) adds the traumatic life event variables to the race adjusted models. 
The total number of traumatic events experienced cumulatively across the life course was not 
associated with either mean grip strength at age 50 or rates of change in grip strength for Black, 
White or Hispanic men (results not shown). However, we did find that traumatic life events 
experienced at the critical life stage of emerging/early adulthood were associated with 
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differences in trajectories of grip strength by race. (Experiencing trauma during childhood or 
midlife was not associated with grip strength trajectories for any race/ethnic group (results not 
shown).) After adjusting for education (Model D, Table 5.2A) Black men who experienced one 
additional trauma in emerging/early adulthood had higher mean grip strength at age 50 (β= 1.66, 
p<.001) and faster rates of decline in grip strength with age (β= -.08, p< .001) than Black men 
who did not experience a traumatic event during this life stage. In contrast, the experience of 
traumatic events was not associated with differences in grip strength trajectories for either White 
or Hispanic men. 
Despite starting out with a higher mean grip strength at age 50, Black men with one 
additional trauma underwent a steeper decline in grip strength with age. Specifically, Black men 
who experienced one additional traumatic event in emerging/early adulthood lose, on average, an 
additional .08 kg in their grip strength each year (β= -.08, p< .001; Model D Table 5.2A). This 
means that, at age 80, for example, Black men who did not experience any traumatic event have 
a predicted grip strength of 33.7 kg while Black men who experienced two traumatic events have 
a predicted grip strength of 27.4 kg—over a 6 kg difference, as shown in Figure 5.2. 
---- Figure 5.2 ---- 
Racial differences in the effects of trauma on trajectories of grip strength have notable 
consequences for the observed disparities in later life grip strength by race. For example, at age 
80, the predicted grip strength for a White man who experienced two traumatic events during 
emerging/early adulthood is comparable to a Black men who experienced no traumatic events 
(34.7 kg vs. 33.7 kg, respectively), indicating that even Black men who are free from the 
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experience of trauma during emerging/early adulthood have similar hand grip strength to White 
men who have experienced two traumatic events during this life stage.  
Life course and Life Stage Stress 
Results for models including the measures of stressful life events are presented in Models 
E and F (Table 5.2A). We found no association between the total number of stressful life events 
and either mean hand grip strength or rates of change in grip strength over time (results not 
shown). However, we did find that experiencing stressful life events during emerging/early 
adulthood was significantly associated with trajectories of grip strength, and these effects varied 
by race. (Stressful life events experienced during midlife were not associated with grip strength 
trajectories.) After adjusting for education (Model F, Table 5.2A) White men who experienced 
one stressful life event during emerging/early adulthood had lower mean grip strength at age 50 
than White men who experienced no stressful life events (β= -.78, p < .01). However, similar to 
the findings for traumatic life events (above), Black men who reported one additional stressful 
life event during emerging/early adulthood had a higher mean grip strength at age 50 (β= 2.4, p< 
.0001) but faster rates of decline in grip strength with age (β= -.06, p< .05) than Black men 
reporting no stressful life events during this life stage. Extrapolating these results to age 80, 
Black men who experience 2 stressful life events in emerging/early adulthood have a predicted 
grip strength at age 80 that is 3 kg lower than Black men who do not report experiencing any 
stressful life events (30.3 kg vs. 33.5, respectively) and fully 4 kg lower than White men who do 
not report any stressful life events (34.5 kg). Predicted trajectories by race and stressful life 
events are plotted in Figure 5.3. 
---- Figure 5.3 ---- 
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Testing Potential Mediating Pathways 
 As a final step in the modeling process, we included the hypothesized mediators in the 
pathway between traumatic/stressful life events and grip strength, including time-varying chronic 
conditions, BMI, smoking status, and physical activity. Since these variables are both potential 
mediators and potential confounders in this longitudinal model, we report these results with 
caution. After entering each hypothesized mediator into both the emerging/early adulthood 
trauma (Model D) and stress (Model F) models (Table 5.2), we found no meaningful change in 
the relationship between stress and trauma on the grip strength intercept and trajectories by 
race/ethnicity. Specifically, the intercept and slope differences found for Black men did not 
change even after including these mediating/confounding variables, indicating that trauma and 
stress in emerging/early adulthood has a net direct effect on grip strength for Black men in later 
life. This also indicates that the observed association between emerging/early adulthood stress, 
trauma and muscle strength is not operating through the time-varying, health behaviors that were 
hypothesized to be on the causal pathway. 
Results for Women 
Descriptive Statistics 
The sample characteristics for Black, White and Hispanic women are presented in Table 
5.1B. Out of the 11,624 women included in the sample, 20% were Black, 67% were White and 
13% were Hispanic. The average age at baseline for White women was slightly older (65.2 
years) compared to Black (62.4 years) and Hispanic (62.2 years) women. Black women had 
higher mean grip strength (27.1 kg) compared to White women (25.7 kg) and Hispanic women 
(24.1 kg). Black women and Hispanic women had a higher mean BMI (31.5 and 29.6 kg/m2, 
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respectively) compared to White women (27.8 kg/m2)  and Black women had a greater 
prevalence of chronic health conditions at baseline (mean 2.2 conditions) compared to White and 
Hispanic women (mean=1.8  conditions for both groups). There were notable racial inequalities 
in attained education with 51% of White women having a high-school education or higher, 
compared to only 43% of Black women and 23% of Hispanic women. White women were also 
more likely to report engaging in moderate physical activity 3 times per week (80.2%) compared 
to 73.1% of Black women and 77% of Hispanic women. Current smoking status was roughly 
comparable across all three groups.  
---- Table 5.1B ---- 
When examining the distribution of lifetime trauma, Black women reported a slightly 
higher mean number of traumas (mean= 1.7 events) compared to White (1.6 events) and 
Hispanic (1.6 events) women. Black women were more likely to report 3 or more traumatic life 
events (30.8%) compared to White women (25.8%) and Hispanic women (28.4% 3). Black 
(33.6%), White (36.4%) and Hispanic women (39.8%) were more likely to report experiencing 
one or more traumatic event during childhood than in emerging/early adulthood or in the midlife 
period. Black women also reported a higher mean number of stressful life events (mean= 1.3 
events) compared to White (.85 events) and Hispanic (.96 events) women. Black women were 
more likely to report experiencing 3 or more stressful life events across the life course (23.4%) 
compared to White (12%) and Hispanic (14.3%) women (p<.05). When examining the timing of 
when these events occurred, Black (34.6%), White (25.2%) and Hispanic (25.2%) women were 
more likely to report experiencing stressful life events during midlife than in emerging/early 
adulthood. 
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Growth Curve Models 
Results for the growth curve models for women are presented in Table 5.2B. 
---- Table 5.2B ---- 
Unconditional Growth Model 
In the unconditional growth model (Model A), the mean grip strength for women at age 
50 is 29.8 kg (the intercept, p< .0001) and there is a significant, negative linear and quadratic 
time effect indicating that grip strength declines over time. Specifically, for each additional year 
of age, women lose, on average .2 kg of grip strength per year (β=-.196, p<.0001) and this 
decline accelerates over time (significant quadratic effect for age).  
Race/Ethnicity 
Model B (Table 5.2B) presents the results after adjusting for race/ethnicity. Hispanic 
women have significantly lower average grip strength at age 50 than White women (27.1 kg vs. 
30.5 kg, respectively (β= -3.4, p< .0001) but experience a slower rate of decline in grip strength 
with age (β = .094, p<.001). Black women have a slightly lower mean grip strength at age 50 
than White women (vs. 30.0kg vs. 30.5kg), respectively, although this difference was not 
statistically significant (β= -.443, p= .27) However, as seen from the predicted trajectories in 
Figure 5.4, Black women experience a slower rate of decline in grip strength with age compared 
to White women (β =.110, p<.001, Model B, Table 5.2B).   
---- Figure 5.4 ---- 
Life Course and Life Stage Trauma 
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We found no association between the total accumulation of traumatic events over the life 
course and women’s grip strength in later life (results not shown). However, we did find that 
traumatic events experienced in emerging/early adulthood proved to be a critical window of 
exposure and varied by race. While traumatic events had no effect on grip strength grip strength 
for either White or Hispanic women, Black women who experienced a traumatic life event over 
emerging/early adulthood had significantly lower levels of grip strength in later adulthood. After 
adjusting for education (Model D, Table 5.2B), Black women who experienced one additional 
traumatic event had significantly lower mean grip strength than Black women who did not 
experience a traumatic event (β= -.69, p < .05). We also tested whether lifetime and life stage 
stressors were associated with grip strength in women but found no significant associations.  
---- Figure 5.5 ---- 
Testing Potential Mediating Pathways 
 While the association between trauma in emerging/early adulthood and mean grip 
strength at age 50 remained significant after adding time-varying chronic health conditions, 
smoking status and physical activity to the model, time-varying BMI significantly attenuated the 
coefficient representing the effect of trauma for Black women (Model D, Table 5.2B). After 
adjusting for time varying BMI, the intercept for Black women who had experienced traumatic 
life events in emerging/early adulthood was reduced (-.69 to -.63) and was no longer significant. 
This suggest that BMI is a partial explanatory factor in the relationship between early adult 
traumatic events and later life grip strength for Black compared to White women. However, we 
present these results with caution, because these variables are both mediators and confounders in 
the longitudinal relationship between life events and grip strength. Further work should test these 
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complex relationships with other analytic methods (i.e., marginal structural models) that are 
better equipped to deal with simultaneous mediating and confounding in longitudinal models.  
5.5     Discussion 
There is growing interest in the life course determinants of muscle strength in older age. 
While a few studies have investigated the role of early life anthropometry and socioeconomic 
status in differential vulnerability to muscle weakness,107,201,202 less is known about how one’s 
lived social experience unfolds over the life course to influence trajectories of grip strength in 
later life. This study is an important contribution to the literature because it not only examined 
longitudinal changes in grip strength over time by race/ethnicity but also considered to what 
extent earlier negative life events impacted grip strength trajectories in later life.  
 There are several key findings from this study. First, we found that life course trauma 
and stress experienced during emerging/early adulthood were associated with differences in 
levels of grip strength and rates of change in grip strength over mid to late adulthood.  
Specifically, among Black men, stress and trauma experienced during emerging/early 
adulthood were not only related to higher mean grip strength at age 50, but also associated with 
steeper declines as individuals aged over time compare to White men. Second, for Black women, 
traumatic events during emerging/early adulthood were associated with lower mean grip strength 
at age 50. Third, the accumulation of traumatic and stressful events across the life course was not 
associated with grip strength in later life for any group. This finding supports the critical period 
hypothesis, whereby experiencing stressful events experienced during emerging/early adulthood 
may have disproportionate negative consequences for maintaining and preserving muscle 
strength in later age, particularly for Black men and women. Lastly, contrary to our hypothesis, 
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no differences in grip strength were observed for White and Hispanic men and women even after 
accounting for stress and trauma.  
To the best of our knowledge, no studies have directly examined the relationship between 
life course social stress and trauma and muscle strength in later age. After considering the type 
and timing of the exposure, our study suggests that one’s lived experience, particularly during 
emerging/early adulthood, is consequential for muscle health in older age.  Findings from this 
study are consistent with previous work documenting a strong association between stress, trauma 
and other physical and mental health. Indeed, there is a well-established literature that has found 
stress and trauma experienced earlier in the life course to be associated with a host of negative 
health outcomes, including depression,203 cardiovascular disease 204 and impaired immune 
function.53 
The mechanism by which social stress and trauma could affect muscle strength is not 
well studied. However, the distinct physiologic cascade the takes place following exposure to 
stressful events is well documented.53 Furthermore, exposure to chronic stress, such as those 
negative events that persist over time (i.e., taking care of a sick family member) or experiencing 
an acute, traumatic event (i.e., being the victim of a crime) are believed to be the most potent 
forms of stress.54 When a stress response is activated, cortisol is released by the hypothalamic-
pituitary-adrenocortical (HPA) axis. While the initial release of cortisol and other hormones is 
viewed as adaptive by slowly digestion and breaking down metabolic compounds in order to 
quickly produce energy, cortisol remains elevated the longest amount of time in the body.54 This 
has been replicated over decades of research demonstrating that repeated activation of the HPA 
pathway is harmful to health. The proposed mechanism, increased inflammation, has grave 
implications for multiple bodily systems, including, but not limited to, the skeletal muscle 
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system.53,54 Indeed, higher levels of interleukin-6 (IL-6), interleukin-1 receptor (IL-1R) and 
tumor necrosis (TNF) and C-reactive protein (CRP), all primary markers of an elevated 
inflammatory state, have been found to be associated with reduced muscle strength.55,56 Based on 
the disproportionate burden of stressful life events experienced by Black men and women 
relative to Whites and Hispanics in our study, we would anticipate that the physiologic wear and 
tear or “weathering”205 could be a salient mechanism leading to impaired muscle strength in later 
life.  
While considering the individual-level, physiologic mechanisms by which stressful 
events “get under the skin” and lead to steeper declines in muscle strength, it is important to 
remember that this is only a partial explanation of the findings observed in this study. Indeed, 
previous scholars have noted that while accounting for non-social factors is valuable, doing so 
“should not preclude consideration of the integral, often antecedent ways racialization may 
condition disease and distributions”.206,207 Previous research on the social determinants of health, 
coupled with recent calls to incorporate Critical Race Theory into the realm of health disparity 
research,208,209 provide a clear rationale for looking at macro, upstream factors in order to 
understand the structural contributors to the racial/ethnic disparities in muscle strength observed 
in this study.  
One of the primary structural drivers of the racial and ethnic disparities observed in 
health operates through structural racism. Structural racism, defined as “the macro-level systems, 
social forces, institutions, ideologies, and processes that interact with another to generate and 
reinforce inequities among racial and ethnic group”210 has insidious consequences for health.207 
A growing body of research has documented how the consequences of structural racism shape 
social and economic inequities that are largely produced along racial and ethnic lines.147,211,212 
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The insidious effects of structural racism on health are multidimensional and far reaching by 
simultaneously restricting access to a myriad of domains that include, but are not limited to, 
health-promoting resources such was wealth, income, safe neighborhoods, quality education and 
healthcare, as well as maintaining a system where socially marginalized groups lack the basic 
and essential resources needed to prevent and treat diseases.213–215  
In this study, Black men and women were more likely to positively endorse items 
pertaining to experiences of major lifetime discrimination, a pervasive symptom of structural 
racism. For example, Black men were more likely to experience being denied a bank loan (20% 
compared to 6% of White and 10% of Hispanic men), prevented from moving into a 
neighborhood because the landlord or realtor refused to sell or rent you a house or apartment 
(12% compared to 1% of White and 2% Hispanic men) and unfairly stopped, searched, 
questioned physically threatened or abused by the police (34% compared to 10% of Whites and 
19% of Hispanic men). These differences were also observed in Black women as well with 14% 
reporting being denied a loan (5% of White and 6% of Hispanic women), 9% reporting not being 
able to move into a certain neighborhood (1% of Whites and 2% of Hispanic women) and 11 
percent endorsing unfair treatment by the police (3% of Whites and 4% of Hispanic women). We 
did not find differences in the grip strength trajectories by stress for White men or women. This 
may be due to the fact that when Whites experience unfair treatment, they are more likely to 
interpret the unfair treatment as an individual and not due to their particular group 
membership.216 
In connecting the distal and proximal pathways stated above, we believe that the 
disparities observed in this study are the result of a larger structural-physiologic pathway 
whereby entrenched macro-level forces of structural racism that operate through stressful 
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experiences of discrimination, stress and trauma, lead to chronic activation of the HPA axis, 
which in turn lead to a wear and tear on the body, that produce declines in muscle strength for 
Black men and women in later life.  
Consistent with a life course approach, we sought to examine whether the timing of when 
stressful and traumatic events occurred matters in preserving muscle strength in older age. We 
found that when trauma and stress were experienced during the emerging/early adulthood period, 
a life stage rooted in distinct transitions and the establishment of key social roles,90,112 muscle 
strength was compromised in later life. In other words, trauma and stress experienced during 
emerging/early adulthood was associated with a faster decline in muscle strength compared to 
those who did not experience any traumatic or stressful events during this same period. 
Therefore, our results suggest that emerging/early adulthood may prove to be “critical period” in 
which excess exposure to stress and trauma may have far reaching and adverse consequences for 
muscle strength compared to other time periods, particularly for Black men and women. Our 
findings are consistent with past work that has found emerging/early adulthood to be a critical 
period for health outcomes in later life. For example, Clarke & Wheaton found that 
consequences of neighborhood poverty and unemployment experienced during the 
developmental period of adulthood (23-38 years of age), compared to other life stages, was 
linked to higher levels of depression in later life.217    
A major finding in this study is that the consequences of trauma and stress were 
experienced differentially with regard to muscle strength in later life. Specifically, Black men 
and women were disproportionately impacted as steeper declines in grip strength were observed 
for both men and women on account of earlier negative events compared to those did not 
experience stressful and traumatic life events during emerging/early adulthood. Although men 
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who experienced one traumatic or stressful event during emerging/early adulthood had higher 
grip strength by the time they reached age 50, this reserve quickly eroded over time such these 
same Black men and women who had experienced stress and trauma earlier in the life course had 
markedly lower grip strength in later life compared to their non-exposed peers. Moreover, the 
grip strength declines observed in this study among Black men were also notable relative to the 
longitudinal changes in White men. In extrapolating our findings, we found that by age 80, the 
grip strength profile of a Black men who had experienced no stressful/traumatic events during 
emerging/early adulthood looked similar to White men who had experienced 2 or more 
stressful/traumatic events, opposite of what we could expect.   
The question as to why experiencing stress and trauma would be especially consequential 
for Black men during emerging/early adulthood with respect to their later life grip strength is not 
fully understood. However, research suggests that racial disparities in health are rarely the result 
of sudden changes in health in later life but rather the byproduct of a long-standing, cumulative 
process subject to larger structural systems of racialization.102,195 In other words, the differential 
vulnerability observed in this study is not due to biological differences, but rather a consequence 
of one’s social context. Through this lens, being exposed to major life stress and trauma during 
emerging/early adulthood, the time in which the establishment of one’s career, marriage, and 
parenting becomes of critical importance to future income, earnings and health status may lead to 
a particularly devastating consequences for Black men. That is, Black men who lack the 
resources and opportunities to rebound and recover due to structural factors may experience far 
reaching effects due to stress and trauma.195 It would follow that the stress Black men experience 
associated with trauma has the potential to derail and limit future opportunities, above and 
beyond experiencing the same events at a different point later in the life course and it is this 
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heightened vulnerability that may compromise health in later life, and in this case, muscle 
strength.  
This study has several strengths. First, to the best of our knowledge, this is the first study 
to investigate the association between stress and trauma and its consequences of muscle strength 
in older age in a racially/ethnically diverse sample of older adults. Second, the results of were 
obtained in a nationally representative sample of adults and can therefore be generalized to 
community-dwelling Black, White and Hispanic adults aged 50 years and older living in the 
United States. Third, we used data that considered not only what type of stressor was 
experienced but at what point in the life course it occurred. This enabled us to apply a life course 
approach in our inquiry of how stress and trauma impacts later life muscle strength. Previous 
studies documenting how early life exposures impact later life health have been largely been 
relegated to examining childhood exposures (i.e., maternal education) due to limits in the 
assessment of life course social experiences. Lastly, a major strength of this study was our ability 
to examine whether muscle strength trajectories differ by race/ethnicity and gender. Past work 
examining longitudinal changes in grip strength have largely focused on White populations.17,47 
Given the rapidly changing demographic makeup of older adults in the United States,3 
understanding how muscle strength changes over time across a variety of groups is essential in 
delaying or preventing the onset of disability, physical functioning limitations in order to 
maximize independence in older age.  
Despite these strengths, this study is not without limitations. First, participants were 
asked to retrospectively recall their exposure to stressful and traumatic events throughout the life 
course. Thus, participants had to rely on their memory of when certain events took place, which 
may be subject to recall bias especially if events that occurred earlier in one’s life history may be 
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more difficult to recall. Despite this potential limitation, previous research has found that when 
individuals are asked to recall the timing of past traumatic events, they do so with reasonable 
accuracy.218 For example, in one study, participants were prospectively assessed via self-report 
as to when they experienced childhood communicable diseases, accident, hospitalizations, 
surgeries and other illnesses, and by age 50, 85% of the these events were correctly recalled.219  
Second, as with any longitudinal study of older adults, we cannot overlook the potential 
for selective survival bias in our sample, particularly among older Black and Hispanic men. 
Previous research estimates that in the HRS, only 40 percent of Black men born between 1931 
and 1941 live to age 60.132 Additionally, because this study did not include those whom are 
homeless or incarcerated, the results presented in this study a likely an underestimate of the true 
association since those who were not enrolled/died before age 50 are likely to be the most 
disadvantaged. Lastly, we were unable to adequately adjust for both mediators and confounders 
as many of the hypothesized mediators in this study could also be considered time-varying 
confounders. Future work in this area should consider other analytic techniques that can 
accommodate both mediator-confounders in order to obtain controlled estimates that are able to 
tease apart the independent effects of mediator and confounding in a longitudinal setting.  
The results of this study underscore the importance of considering how structural systems 
of inequality, as experienced through life course exposure to stress and trauma, lead to steeper 
declines in muscle strength, particularly among older Black men and women. Moreover, we 
believe these findings are a call to action for future research in this area by focusing less on 
individual-level risk factors of muscle strength in older life and begin placing greater emphasis in 
the inquiry of how one’s social context shapes trajectories of muscle strength as adults age over 
time.  
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5.6    Tables and Figures 
Table 5.1A Baseline descriptive statistics for Men in the Health and Retirement Study, N=8,847 
(2006-2014). 
 
Black Men White Men Hispanic Men 
 
(n=1506) (n=6200) (n=1127) 
Variable Mean* (SD) 
Mean* 
(SD) Mean* (SD) 
Age (in years) (range 46-99) 61.1 (9.0) 63.5 (10.3) 61.1 (8.9) 
Grip Strength (kg) 42.1 (10.1) 43.6 (9.8) 39.8 (9.2) 
Chronic Conditions (Range: 0-8) 1.9 (1.5) 1.8 (1.5) 1.7 (1.4) 
Body Mass Index (kg/m2) 28.6 (5.5) 28.5 (5.1) 29.2 (5.1) 
  %* %* %* 
Education    <HS 57.7 41 71.8 
≥ HS 42.3 59 28.2 
Physical Activity    Inactive/Sedentary 16.9 14.7 15 
Active 83.1 85.3 85 
Smoking    Current 19.1 13.5 14.6 
Former 46 48.7 49.1 
Never 34.8 37.8 36.4 
Traumatic Events Across Life Course  
(range 0-11)    
0 24.5 22.3 24 
1 21.3 26.8 25.2 
2 21.2 21.4 18 
3 13.2 14.8 13.4 
4 11.2 7.9 8 
5+  8.6 6.8 10.8 
Stressful Events Across the Life Course  
(range 0-11)    
0 30 44 40.5 
1 22 23.2 23.5 
2 15.7 13.6 14.1 
3 10.5 9.2 8.6 
4+ 21.8 10 13.4 
Traumatic Events Across Life Stages 
   Early childhood trauma (0-17 years)    0 50.3 53.2 49.6 
1 30.3 29.9 29.8 
2 14 12.2 13,8 
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3+ 5.5 4.8 6.8 
Emerging adulthood trauma (18-42 years)    0 69.3 69.3 69.4 
1 21.4 21.8 22.8 
2 6.9 6.9 6.5 
3+ 2.5 2.1 1.3 
Midlife trauma (43-67 years)    0 68 65.8 68.1 
1 21.2 24.4 19.5 
2 7.2 7.4 9.1 
3+ 3.6 2.4 3.3 
Stressful Events Across Life Stages    Emerging adulthood stress (18-42 years)    0 70.4 80.4 82.8 
1 17.7 14.2 9.6 
2 7.7 4.4 6.2 
3+ 4.2 1 1.4 
Midlife stress (43-67 years)    0 60.7 68 63.5 
1 20.6 17.2 19.2 
2 9.6 7.3 8.5 
3+ 9 7.4 8.7 
*Weighted mean and percentages       
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Table 5.2A Growth curve models for hand grip strength in Men in the Health and Retirement Study (N=8,847), 2006-2014. 
  
Unconditional 
Growth 
Model 
+Race/ 
Ethnicity 
+ Trauma in 
Emerging/Early 
Adulthood  
+Trauma and 
Education 
 Stress in 
Emerging/Early 
Adulthood 
+ Stress 
and 
Education 
 Model A Model B Model C Model D Model E Model F 
Intercept 48.58*** 50.27*** 50.39*** 50.63*** 50.64*** 50.89*** 
Race/Ethnicity       
Blacks  -3.56*** -3.39*** -3.26*** -3.89*** -3.38*** 
Hispanics  -4.89*** -4.67*** -4.43*** -5.13*** -4.88*** 
Education       
≤HSa    -0.71***  -0.701*** 
Traumatic Events   -0.013 -0.024   
Trauma*Black   1.7** 1.66**   
Trauma*Hispanic   -4.67*** -0.412   
Stressful Events     -.764** -0.779*** 
Stress*Black     2.42*** 2.40*** Stress*Hispanic     1.09 1.04               
Rate of Change       
Age -0.308*** -0.339*** -.34*** -.336*** -.347*** -.342*** 
Age2 -.007*** -.007*** -0.007*** -.007*** -.007*** -.007*** 
Race/Ethnicity       
Blacks*Age  0.024 -0.004 -0.004 0.009 0.009 
Blacks*Age2  0.002 0.002 0.003 0.002 0.002 
Hispanics*Age  -0.09 -0.082 -0.086 -0.061 -0.066 
Hispanics*Age2  0.003 0.032 0.002 0.002 0.002 
Traumatic Events       
Trauma*Age   0.007 0.007   
Stressful Events       
Stress*Age     0.016 -0.014 
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Trauma & Race/Ethnicity       
Trauma*Black*Age   -.08** -.081**   Trauma*Hispanic*Age   0.032 0.031   
Stress & Race/Ethnicity       
Stress*Black*Age     -.063* -.062* Stress*Hispanic*Age     -0.023 -0.021 
       
       
Goodness-of-Fit Statistics       BIC 167264.4 166857.7 145419.7 14515.1 14.5549.7 145545.2 
Within Person Variance 13.04 13.01 13.25 13.25 13.25 13.26 
Pseudo R2  0.23 0.02 0.02 0.02 0.02 
* p<.05 
      ** p<.01       
*** p<.001        a Reference is High School degree or higher       
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Figure 5.1 Grip strength growth curve trajectories for Men by Race/ethnicity in the Health and Retirement Study (N=8,847), 2006-
2014. 
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Figure 5. 2 Grip strength growth curve trajectories for Men by Race/ethnicity and Levels of Traumatic Events in the Health and 
Retirement Study (N=8,847), 2006-2014. 
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Figure 5. 3 Grip strength growth curve trajectories for Men by Race/ethnicity and Levels of Stressful Events in the Health and 
Retirement Study (N=8,847), 2006-2014. 
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Table 5.1B Baseline descriptive statistics for Women in the Health and Retirement Study (N=11,624), 2006-
2014. 
 
Black  
Women 
White 
Women 
Hispanic 
Women 
 
(n=2,354) (n=7,797) (n=1,458) 
Variable Mean* (SD) Mean* (SD) Mean* (SD) 
Age (in years) (range 46-99) 62.4 (9.6) 65.2 (10.7) 62.2 (9.4) 
Grip Strength (kg) 27.1 (6.9) 25.7 (6.5) 24.1 (5.9) 
Chronic Conditions (Range: 0-8) 2.2 (1.4) 1.8 (1.4) 1.8 (1.4) 
Body Mass Index (kg/m2) 31.5 (7.3) 27.8 (6.2) 29.6 (6.4) 
  %* %* %* 
Education     <HS 57.3 48.6 77 
≥ HS 42.8 51.4 23 
Physical Activity    Inactive/Sedentary 26.9 19.8 23.4 
Active 73.1 80.2 76.6 
Smoking    Current 14.2 12.5 9.1 
Former 36.8 37.6 35.2 
Never 49 49.9 55.7 
Traumatic Events Across Life Course 
(range 0-11)    
0 28.2 26 29.5 
1 22.6 28 21.7 
2 18.4 20.2 20.5 
3 15.8 13.1 15 
4 7.3 7.4 6.6 
5+  7.7 5.3 6.8 
Stressful Events Across the Life Course 
(range 0-11)    
0 40.3 55 51.5 
1 22.2 21.5 22.1 
2 14.2 11.5 12.2 
3 10.2 6.4 7.3 
4+ 13.2 5.6 7 
Traumatic Events Across Life Stages 
   Early childhood trauma (0-17 years)    0 66.4 63.6 60.2 
1 23.5 25.6 27.9 
2 8.1 7.9 9.3 
3+ 2 2.9 2.6 
Emerging adulthood trauma (18-42 years)    0 73.2 74.5 64.4 
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1 19 18.4 24.2 
2 6.5 5.2 8.7 
3+ 1.3 1.8 2.8 
Midlife trauma (43-67 years)    0 66 64.4 70.3 
1 24.7 24.1 20.2 
2 7.2 8.7 6.1 
3+ 2 2.8 3.3 
Stressful Events Across Life Stages    Emerging adulthood stress (18-42 years)    0 82.2 87.8 90.8 
1 12.7 9.3 7.6 
2 3.3 2.1 1.1 
3+ 1.8 0.8 0.5 
Midlife stress (43-67 years)    0 65.4 74.8 74.8 
1 18.7 13.7 11.5 
2 8.4 5.9 8 
3+ 7.5 5.6 5.7 
*Weighted percentages 
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Table 5.2B Growth curve models for handgrip strength in Women in the Health and Retirement Study (N=11,624), 2006-2014. 
 
  Unconditional Growth Model +Race/Ethnicity 
+ Trauma in 
Emerging/Early 
Adulthood  
+Trauma and  
Education 
 Model A Model B Model C Model D 
Intercept 29.84*** 30.47*** 30.68*** 31.91*** 
Race/Ethnicity     
Blacks  -0.443 -0.131 -0.072 Hispanics  -3.38*** -3.59*** -3.42*** 
Education     
≤HSa    -.566*** 
Trauma During Emerging Adulthood    -0.077 0.108 
Trauma*Black   -0.661* -0.689* Trauma*Hispanic   0.009 0.001 
          
Rate of Change     Age -0.196*** -0.238*** -.246 -.247*** 
Age2 -.004*** -.003*** -.003 -.003*** 
Race/Ethnicity     
Blacks*Age  .110*** .117*** .113*** 
Blacks*Age2  .002** -.002** -0.002* 
Hispanics*Age  0.094** .139*** .129** 
Hispanics*Age2  -0.001 -0.003** -.003* 
Trauma Events     
Trauma*Age   -0.077 0.001 
Trauma & Race/Ethnicity     
Trauma*Black*Age   0.026 -.027 
Trauma*Hispanic*Age   -0.013 -0.013 
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Goodness-of-Fit Statistics     
BIC 199489.7 199196.4 179686.7 179688.6 
Residual 6.354 6.352 6.47 6.48 
Pseudo R2  0.00 0.02 0.02 
     
     
* p<.05 
    ** p<.01     *** p<.001      a Reference is High School degree or higher     
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Figure 5. 4 Grip strength growth curve trajectories for Women by Race/ethnicity in the Health and Retirement Study (N=11,624), 
2006-2014. 
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Figure 5. 5 Grip strength growth curve trajectories for Women by Race/ethnicity and Levels of Stressful Events in the Health and 
Retirement Study (N=11,624), 2006-2014. 
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Table 5.3 A Traumatic Life Event Questions from the HRS Participant Leave-Behind 
Questionnaire  
For each of the following events, please indicate whether the event occurred AT ANY POINT IN 
YOUR LIFE. If the event did happen, please indicate the year in which it happened MOST 
RECENTLY. (Mark (X) one box for each line. If "Yes", indicate which year.) 
1. Has a child of yours ever died? 
2. Have you ever fired a weapon in combat or been fired upon in combat? 
3. Has your spouse, partner, or child ever been addicted to drugs or alcohol? 
4. Have you ever been in a major fire, flood, earthquake, or other natural disaster? 
5. Did you ever have a life-threatening illness or accident? 
6. Were you the victim of a serious physical attack or assault? 
7. Did your spouse or a child of yours ever have a life-threatening illness or accident? 
 
 
For this next set of events, please think about your childhood growing up, BEFORE YOU 
WERE 18 YEARS OLD. (Mark (X) one box for each line.)  
 
8. Before you were 18 years old, did you have to do a year of school over again? 
9. Before you were 18 years old, did either of your parents drink or use drugs so often that it 
caused problems in the family? 
 
10. Before you were 18 years old, were you ever physically abused by either of your parents? 
11. Before you were 18 years old, were you ever in trouble with the police? 
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Table 5.3 B Stressful Life Event Questions from the HRS Participant Leave-Behind 
Questionnaire. 
For each of the following events, please indicate whether the event occurred AT ANY POINT IN 
YOUR LIFE. If the event did happen, please indicate the year in which it happened MOST 
RECENTLY. (Mark (X) one box for each line. If "Yes", indicate which year.) 
CHAPTER 1. At any time in your life, have you ever been unfairly dismissed from a job? 
CHAPTER 2. Have you ever been unfairly denied a promotion? 
CHAPTER 3. Have you ever been unfairly prevented from moving into a neighborhood because 
the landlord or a realtor refused to sell or rent you a house or apartment? 
 
CHAPTER 4. For unfair reasons, have you ever not been hired for a job? 
CHAPTER 5. Have you ever been unfairly stopped, searched, questioned, physically threatened, 
or abused by the police? 
 
CHAPTER 6. Have you ever been unfairly denied a bank loan? 
Now please think about the LAST 5 YEARS and indicate whether each of the events below 
occurred. If the event did happen, please indicate the year in which it happened MOST 
RECENTLY. (Mark (X) one box for each line. If "Yes", indicate year.) 
CHAPTER 7. Have you involuntarily lost a job for reasons other than retirement at any point in 
the past five years? 
 
CHAPTER 8. Was anyone else in your household unemployed and looking for work for longer 
than 3 months in the past five years? 
 
CHAPTER 9. Have you moved to a worse residence or neighborhood in the past five years? 
 
CHAPTER 10. Have you been unemployed and looking for work for longer than 3 
months at some point in the past five years? 
 
CHAPTER 11. Were you robbed or did you have your home burglarized in the past five 
years?
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CHAPTER 6.  Conclusions 
6.1 Summary and Implications of Main findings 
There is increasing recognition that muscle strength, as measured by hand grip strength, 
is an important and independent indicator of future negative health outcomes. The muscle health 
field is currently undergoing a shift as it begins to embrace the utility of handgrip strength, as 
opposed to muscle mass, as a primary indicator of muscle weakness and even sarcopenia. This is 
due to the fact that not only is grip strength a reliable proxy of total body muscle strength, but it 
is also an easy and cost-effective tool to assess muscle health in both clinical and epidemiologic 
settings to identify those most at risk for adverse health consequences. However, despite this 
recent evolution in promoting the use of handgrip strength in the assessment of muscle 
weakness, there is currently no agreed upon standard as to how best to measure muscle weakness 
at the population level. As a result, the long-term health outcomes and life course social 
determinants of muscle strength using representative, longitudinal data remain poorly 
understood.  
The primary goals of this dissertation were to: (1) chart new territory for muscle health 
screening at the population level; (2) ascertain the clinical parameters of muscle weakness across 
the diversity of the US older adult population; (3) determine the impact of weakness on disability 
and premature mortality; (4) identify the life course determinants of muscle weakness and how 
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they impact trajectories of grip strength in later life; and, lastly (5) to provide critical information 
that can be used to influence policy decision-making to address much needed interventions for 
those most at risk. To that end, the findings presented in this dissertation advance our knowledge 
in each of these goals in order to improve muscle health in both the clinical setting and at the 
population level.  
In Chapter 2, we addressed an ongoing debate regarding how best to measure muscle 
weakness and whether differences exist in a diverse sample of older adults. Up until this study 
was conducted, the examination of muscle weakness had been largely unexplored across various 
sub-populations since previous research had failed to include non-White populations in the quest 
for consensus surrounding the definition of muscle weakness. Additionally, the majority of 
studies previously conducted had not utilized nationally representative data, which is imperative 
when seeking to make clinical and policy recommendations for older Americans.  
Our study findings indicated that a one-size-fits-all approach in measuring weakness may 
not be appropriate as CART models identified different cutpoints for clinical muscle weakness 
by race/ethnicity in addition to gender. When estimating the prevalence of muscle based on these 
cutpoints, we found that burden of muscle weakness was high across all sub-groups, although 
Black men and women were disproportionately affected. Fifty-five percent of men and 47% of 
women were classified as weak. The proportion of weakness was even higher among Blacks 
with 57% of men and 88% of women being classified as weak.  
The results of this study have important implications for both clinical and epidemiologic 
practice. Given the emerging burden of weakness at the population level, the use of nationally 
representative data provides a critical first step in informing screening efforts to identify 
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individuals who may be a greatest risk, and ultimately, for determining where best to direct 
preventive interventions. Additionally, the results generated from this study are the first to 
address an important and stark health disparity of weakness among Black Americans, a group 
that has been largely overlooked in the muscle weakness literature, despite being at greater risk 
for physical functioning deficits and disability in later life.130 Therefore, the findings presented in 
Chapter 2 significantly moves the field forward in identifying cutpoints for Blacks while 
simultaneously shedding light on emerging health disparities that, if left untreated, could 
potentially lead to a disproportionate burden of disability among older Black Americans. These 
findings also emphasize the importance of working with data that reflects the diverse, older adult 
population.  
In Chapters 3 and 4, we applied the muscle weakness cutpoints generated from Aim 1 to 
examine the long-term health consequences of muscle weakness. We undertook two separate 
analyses to investigate whether muscle weakness was associated with disability dynamics and 
premature mortality. Additionally, since we defined baseline weakness based on the cutpoints 
established in the first aim, we were seeking to test the validity of the cutpoints in predicting 
long-term health outcomes in an ethnically diverse and nationally representative dataset.  
When examining the association between muscle weakness and disability dynamics in 
Chapter 3, we found that, compared to non-weak individuals, the odds of experiencing an onset 
of ADL disability was 54% higher among weak individuals. We also found that the odds of 
experiencing a progression in physical disability status was more than two times higher for weak 
individuals compared to non-weak individuals at baseline across a 2-year period. The results 
generated from this aim are a major contribution to the literature since the majority of existing 
studies examining the longitudinal consequences of muscle weakness have used a dichotomous 
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definition of disability (i.e., presence/absence). This aim extends past work by employing a 
deeper examination of muscle weakness by exploring the onset, persistence and progression of 
disability outcomes, which has not been done before in a nationally representative, diverse 
sample of older Americans. 
 The results from this study are important for several reasons. First, these findings 
provide support for the prognostic utility of the population-derived muscle weakness cutpoints 
identified as identified Aim 1 (Chapter 2). These data have implications for public health 
screening and intervention efforts cannot be fully realized until clinical and epidemiologic 
communities coalesce around standardized cutpoints to identify individuals who may be a 
greatest risk.  Second, by examining the development of disability onset, progression and 
persistence of disability we found that muscle weakness may in fact influence the pace of 
disability. This also has important implications for older adults since previous research has 
shown that disability onset and progression are associated with increased risk of 
hospitalization,162 institutionalization,163 and mortality.164 Finally, our results provide public 
health support for tailoring interventions to each individual’s unique dynamic disability status in 
an effort to prevent steeper declines as individuals’ age. 
We also examined whether the muscle weakness cutpoints from Aim 1 were associated 
with premature mortality in Chapter 4. Specifically, we used the cutpoints to determine weakness 
status at baseline and examined whether weak individuals were more likely to die earlier, 
compared to non-weak individuals across a 9-year period. In this study, we showed that muscle 
weakness, as indexed by the validated thresholds of handgrip strength in Aim 1, was strongly 
associated with early mortality, even after accounting for other known risk factors. Across a 9-
year follow-up period with time-varying measures of weakness, older adults classified as weak 
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were 50% more likely to die earlier compared to those who were not weak, even after adjusting 
for other time-varying risk factors.  
The results from this study provided several important insights. First, muscle weakness, 
as defined by our cutpoints, is associated with long-term mortality. In other words, weak 
individuals are more likely to die earlier compared to those who are non-weak. Therefore, our 
data make a strong case for clinicians to incorporate handgrip assessments into medical practice 
for screening and identifying at risk older individuals. Second, since mortality is an important 
public health outcome that indicates how well the population is fairing, these results should not 
be taken lightly given the rapidly growing older adult population. The high prevalence of obesity 
combined with lower physical activity levels among Baby Boomers indicates that the proportion 
of weak individuals could increase exponentially in the coming years, which could potentially 
translate into an increase in premature mortality due to muscle weakness. As a result, reducing 
the burden of muscle weakness across individuals to improve population health is of critical 
importance.  
In Chapter 5, we examined whether stress and trauma experienced across the life course 
were associated with grip strength trajectories in later life. In addition, we also tested whether the 
timing of when these stressful and traumatic events occurred were associated with changes in 
grip strength over time. Several important findings emerged from this study: First, life course 
trauma and stress experienced during emerging/early adulthood was associated with both mean 
grip strength at age 50 and trajectories of grip strength over time. Specifically, among Black 
men, stress and trauma experienced during emerging/early adulthood was not only related to 
higher mean grip strength at age 50, but also associated with steeper declines as individuals aged 
over time compare to White men. Second, for Black women, traumatic events during 
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emerging/early adulthood were associated with lower mean grip strength at age 50. Third, the 
accumulation of traumatic and stressful events across the life course was not associated with grip 
strength in later life for any group. This finding supports the critical period hypothesis, whereby 
experiencing stressful events experienced during emerging/early adulthood may have 
disproportionate negative consequences for maintaining and preserving muscle strength in later 
age, particularly for Black men and women.  
The results of this study have several important implications. First, since we examined 
handgrip strength as a continuous variable instead of relying cutpoints validated in a 65+ sample, 
we were able to include younger individuals into this analysis whom had previously been 
excluded. This enabled us to expand our line of inquiry to examine mean grip strength at age 50 
and how grip changes over time during the critical transition from midlife to older age.  Our 
results provide support for studying muscle weakness earlier in the life course in order to reduce 
and even avoid rapid declines in muscle strength in later life. Since it is estimated the declines in 
muscle start at around age 30 and accelerate after age 50,19,220 implementing interventions to 
preserve muscle during this time period are critically important. Second, our findings underscore 
the importance of considering how structural systems of inequality, as experienced through 
exposure to stress and trauma, lead to steeper declines in muscle strength, particularly among 
older Black men and women. While there is well established literature linking structural racism 
to cardiovascular disease, blood pressure, premature birth, and a host of other negative health 
outcomes,207,211,215 to the best of our knowledge no studies have examined how structural racism 
and inequality, through exposure to stress and trauma, get the under the skin and into the muscle 
to impact trajectories of muscle strength over time. Thus, the findings presented in this aim have 
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important implications for the muscle weakness field and represent an important new avenue for 
research.  
6.2 Strengths and Limitations 
 While this dissertation is at the forefront in our understanding of muscle weakness among 
older adults, it has several important limitations that warrant discussion. First, we derived 
cutpoints for clinical muscle weakness based on having a slow gait speed (less than 0.8 meters 
per second). While this outcome was used by the FNIH and has been shown to be independently 
associated with early mortality,139 it is limited on several fronts. In Aim 1 (Chapter 2), Black 
men and women were more likely to be overweight/obese which would translate into a slower 
walking speed since these individuals have more mass to move. This may account for the 
unexpected paradox that, despite Black men and women having a higher mean grip strength, 
there were more likely to be clinically weak based on the cutpoints, which is opposite to what we 
would expect. Given the high prevalence of obesity and slow walking speed, it is unclear if slow 
walking speed is the right calibrating variable across various sub-populations, particularly among 
those who have a higher prevalence of obesity. Since the FNIH proposed cutpoints that based on 
non-representative, pooled data, more research is needed regarding the application of different 
calibrating variables using diverse, representative samples and how this affects cutpoints for 
muscle weakness across various sub-groups. 
 Second, as an extension to the previous point, another limitation of this dissertation is that 
we derived cutpoints for muscle weakness among older adults aged 65+ years. As a result, we 
were only able to include samples that were aged 65 years and older when examining the 
consequences of muscle weakness in Chapter 3 and 4. While these cutpoints are an important 
contribution to the literature since they were derived in a nationally representative sample and 
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examined differences by gender and race/ethnicity, we were limited in our ability to derive 
cutpoints among younger adults because walking speed was only collected among individuals 
aged 65+ years. Indeed, the results from Chapter 5 coupled with a growing literature indicating 
that midlife is a critical time for intervention,14,221 underscores the importance of considering 
younger populations in the study of muscle weakness.  
Third, handgrip strength is a reliable proxy for total body muscle strength44 and is simple, 
cost-effective measure to use, however, it is note routinely assessed in the clinical setting. The 
Centers for Medicare and Medicaid Services (CMS) Clinical Quality Measures, which specifies 
the recommended core measures for adult recipients of both Medicare and Medicaid, has not 
recommended the assessment of muscle strength as part of their priority health care improvement 
goals. And, when grip strength is assessed, there is wide variability in the protocol used to assess 
weakness with respect to numerous variables, including, but not limited to, body position (wrist, 
forearm, elbow, shoulder), posture, effort, encouragement, and the type of dynamometer used, 
for example.222 Despite this limitation, the results presented in this dissertation, which utilized 
hand grip strength from the HRS, has a detailed protocol that is consistent with other large-scale 
epidemiologic studies that have also collected grip strength data.62 
Lastly, an inherent limitation of conducting research in older adult populations is the 
potential for selective survival. Selective survival poses a threat to internal validity if attrition is 
systematic or related to the outcome of interest. Since we excluded those who are homeless, 
incarcerated or in a nursing home in Chapters 2-5, and only included those age 65 years and 
older (Chapters 2, 3, &4), selective survival may be at play. This may be especially problematic 
in the estimates obtained for Blacks because of the reduced life expectancy compared to 
Whites.223 Therefore, we would expect that the results presented in each of these aims are likely 
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an underestimate of the true association since individuals who are excluded or die before the 
inclusion age are more likely to be sicker, have higher rates of disability and represent the most 
disadvantaged.  
This dissertation has several strengths. First, the results presented in this dissertation 
utilized data from the Health and Retirement Study (HRS). The HRS is the longest running 
nationally representative, longitudinal study of Americans aged 50 years and older. Therefore, 
the research findings generated from this dissertation can be generalized to older Americans aged 
65 years and older (and 50 years and older in Chapter 5) since the study sample is nationally 
representative. This is a particularly important strength since previous research examining 
muscle strength has tended to rely on small-scale, clinical datasets. 
 Second, we uniquely conceptualized both exposure and outcome variables as 
demonstrated in several chapters. For example, in Chapter 3, we employed a dynamic definition 
of disability status that sought to capture the fluidity of physical limitations in activates of daily 
living. Previous research investigating disability and muscle weakness have relied on a static 
definition of disability that does not reflect the changing nature of physical functioning over 
time. Similarly in Chapter 5, we examined stress and trauma as a primary exposure in 
investigating its association with muscle strength in later life. While accounting for this social 
exposure was novel in and of itself, we also applied a life course approach to our understanding 
of one’s lived experience by incorporating at what point in the life course these exposures were 
experienced. To the best of our knowledge, no studies have investigated life course exposure to 
stress and trauma and its impact on muscle strength in later life.   
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 Third, while the incorporation of grip strength in routine practice remains a formidable 
challenge, the application of handgrip strength in both the clinical and epidemiologic setting is a 
major strength to study of muscle weakness. Hand grip strength has been shown to be cost-
effective, reliable proxy for total body muscle strength that can be easily administered in the 
clinical setting 43,174. Compared to other measures of muscle weakness such as, body impedance 
analysis, DXA and muscle biopsy, a dynamometer is a small, simple and inexpensive device that 
is both easy to administer and non-invasive 43.   
6.3 Public Health Significance and a New Path Forward 
This dissertation builds upon previous work that has shown muscle weakness to be an 
important determinant of physical health in later age. However, the collective results generated 
from this dissertation extend well beyond this conclusion and lay the groundwork for a new path 
forward in the study of muscle strength. This has been accomplished on several fronts. First, we 
incorporated the measurement of dynamic processes in relation to muscle weakness. In Chapter 
3, we examined dynamics of disability and how muscle weakness influenced the onset, 
progression and persistence ADL limitations in a longitudinal setting. In Chapter 4, we examined 
the association between time-varying muscle weakness and mortality rather than relying on 
baseline muscle weakness. And, in Chapter 5, we focused on the dynamic timing by which 
stressful and traumatic life experiences occur to influence muscle strength trajectories in later life 
by accounting for different stages across the life course. 
 Second, this dissertation charts a new path forward by bringing grip strength research into 
the real world. Instead of relying on highly selective clinical samples, we utilized data from a 
nationally, representative sample of Black and White older adult adults aged 65 years and older 
in Chapter 2. Thus, the cutpoints generated from this aim have major public health significance 
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because they can be applied to older American adults as opposed to a select few. Additionally, 
the cutpoints require no special calculations or norming and could therefore be readily 
implemented within the clinical setting. 
 Third, and perhaps of most importance, this dissertation brings a social epidemiologic 
lens to the study of muscle strength. This is an essential step forward because, to date, most work 
conducted within the study of muscle weakness has predominately relied on risk-factor 
epidemiology and focused on individual level interventions without acknowledging the larger 
structural forces that shape risk to muscle weakness at the population level. This approach is 
problematic because individuals are embedded within populations and therefore the “risk of 
illness cannot be considered in isolation from the disease risk of the population in to which she 
belongs”.224 Therefore, the integration of a social epidemiology combined with a traditional 
epidemiologic approach enabled us to identify the distribution of muscle weakness at the 
population level (Chapter 2), identify its health outcomes (Chapters 3 and 4) and consider the 
social conditions that drive declines in muscle strength in later life (Chapter 5).  
6.4 Future Directions 
 The penultimate chapter in this dissertation serves as a fertile jumping off point for future 
research. While we present a compelling case for considering why the social context is important 
for the preservation of muscle strength in later life, the underlying mechanism by which this 
occurs remains unknown. A closer examination of the causal pathway that explores the complex 
relationship between one’s social context and muscle weakness in older age is warranted. 
Neighborhood residence has been shown to be a salient explanatory mechanism in 
understanding the pathway between socioeconomic conditions experienced in childhood and 
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later life health outcomes because of the social and physical attributes that effect individual 
health.225,226 The neighborhood built environment is associated with obesity,227 hypertension,228 
coronary heart disease229 and mobility disability.230 Therefore, one possible pathway of future 
exploration is examining the “long arm” 218,231 of childhood SES and how it shapes where one 
lives, the neighborhood level conditions and resources individuals are exposed to and the 
subsequent health behaviors that emerge on account of ones surroundings, and, ultimately how it 
influences who may be at greatest risk for muscle weakness as one ages.  
This has never been examined as research on muscle weakness has almost exclusively 
focused on later adulthood, at a time when it becomes a clinical condition and interventions may 
be less effective. Future work should focus on examining how early life childhood SES, as 
mediated through cumulative exposure to neighborhood factors and health behaviors, influence 
the onset of muscle weakness in early and midlife adulthood in order to delay or prevent the 
onset of muscle weakness in older age. 
6.5 Conclusion 
I hope the results from my dissertation research can be utilized to advance clinical 
research while helping to identify the underlying mechanisms and structural processes of muscle 
weakness in order to improve muscle health at the population level. It is also my hope that by 
understanding the early determinants of weakness and their impact on health related outcomes, 
we can create effective early interventions leading to improved health, mobility and enhanced 
overall well-being, especially among the most vulnerable Americans.
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